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ABSTRACT OF THE DISSERTATION 
INTRACELLULAR SIGNALING AND TRAFFICKING IN CANCER:  ROLE OF 
RAB5-GTPASE IN MIGRATION AND INVASION OF BREAST CANCER CELLS 
by 
Nicole C. Porther 
Florida International University, 2015 
Miami, Florida 
Professor Manuel A. Barbieri, Major Professor 
Metastasis is characterized pathologically by uncontrolled cell invasion, proliferation, 
migration and angiogenesis. Steroid hormones, such as estrogen, and growth factors, 
which include insulin growth factor I/II (IGF-1/IGF-2) therapy has been associated with 
most if not all of the features of metastasis. It has been determined that IGF-1 increases 
cell survival of cancer cells and potentiate the effect of E2 and other ligand growth 
factors on breast cancer cells. However not much information is available that 
comprehensively expounds on the roles of insulin growth factor receptor (IGFR) and Rab 
GTPases may play in breast cancer. The latter, Rab GTPases, are small signaling 
molecules and critical in the regulation of many cellular processes including cell 
migration, growth via the endocytic pathway. This research involves the role of Rab 
GTPases, specifically Rab5 and its guanine exchange factors (GEFs), in the promotion of 
cancer cell migration and invasion. Two important questions abound: Are IGFR 
stimulation and downstream effect involved the endocytic pathway in carcinogenesis?  
What role does Rab5 play in cell migration and invasion of cancer cells? The hypothesis 
is that growth factor signaling is dependent on Rab5 activity in mediating the 
vi 
aggressiveness of cancer cells. The goal is to demonstrate that IGF-1 signaling is 
dependent on Rab5 function in breast cancer progression. Here, the results thus far, have 
shown that while activation of Rab5 may mediate increased cell proliferation, migration 
and invasion in breast cancer cells, the Rab5 GEF, RIN1 interacts with the IGFR thereby 
facilitating migration and invasion activities in breast cells.  Furthermore, endocytosis of 
the IGFR in breast cancer cells seems to be caveolin dependent as the data has shown. 
This taken together, the data shows that IGF-1 signaling in breast cancer cells relies on 
IGF-1R phosphorylation, caveolae internalization and sequestration to the early 
endosome RIN1 function and Rab5 activation. 
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CHAPTER 1 
 The scope of this chapter is to introduce the concept of intracellular signaling 
cascade in normal and cancer cells with specific focus on early endocytosis and growth 
factor receptor activity upon ligand stimulation. The role of Rab GTPases, key metastatic 
traits (cell invasion and cell migration), and a short overview of the insulin growth factor 
pathway will be covered in cancer cells. Overall the information creates an outline for the 
research hypothesis. 
1.1 Introduction 
The last decade in cancer research has seen great strides in identifying the interplay 
between the stroma and tumor environment in cancer progression. Briefly, cancer has 
been long viewed as a disease consisting of transformed or mutated cells that acquire 
hyper-proliferative, invasive and limitless survival capacities. While this in itself is true, 
it was a limited approach as ensuing therapeutic cancer intervention strategies sought to 
target only the tumor cell. However, carcinogenesis and tumor progression are viewed 
not as an autonomous cell-centered condition, but rather as a disease involving complex 
multicellular (stromal cells) crosstalk within a newly formed tissue. This breast cancer 
tissue or the tumor matrix hijacks key cellular functions which have evolved as 
cornerstones of metastasis. The primary focus of this review will delve on the early 
endocytic pathway in modulating one of the most important hallmarks of cancer cell 
metastasis; cell migration and cell invasion in response to growth factor stimulation. 
1.2 The Traits of Cancer 
Hanahan and Weinberg published a landmark paper referred to as the ‘Hallmarks of 
Cancer’ that encapsulated the key stages from tumorigenesis to metastasis in cancer 
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progression 53. The six phases described, though distinctive in nature, complemented each 
other and worked in concert in the transformation a normal cell to a cancer cell. These 
hallmarks were later updated to ten key traits by the authors and include but not limited to 
tumor induced inflammation to the constitution and signaling interactions of the tumor 
microenvironment in the maintenance of cancer phenotypes. For this project, three 
hallmarks were studied: sustained proliferation, migration and invasion. 
1.2.1. Always On: Growth Factor sustained proliferation 
The multiplication of cells relies on biochemical molecules called growth factors141 
that are highly bio-reactive despite their low copy number within tissues. Their primary 
functions include cell growth, differentiation and survival thereby making them targets 
for opportunistic pre-cancer cells. During normal body function, homeostasis is achieved 
by the regulation of the production and secretion of growth signals (mitogens) and the 
cells that respond and progress from a quiescent status to the growth and division 
cycle141.  
Cancer cells, on the other hand, modulate these mitogenic signals and evolve as 
autonomous growth signal entities64,71,141. They upset the delicate balance by promoting 
the binding of multiple growth factors to cell surface receptors, synthesize growth signals 
that can either bind to their own receptor forming an autocrine loop or influence the 
secretion of more growth factors by normal cells into the stroma 12,25, which then binds 
again to the receptors on the cancer cells, creating a paracrine feedback loop.  
Within the cancer cell, activated receptors transduce signals via the intracellular 
signaling pathway resulting in increased cell proliferation, survival and size and 
3 
translation of more modified cell surface receptors which continue to feed into the self-
sufficient, machinery created by cancer cells53,117. These receptors may also be altered 
where they are permanently activated and hyper-sensitive to various stimuli or non-
specific ligand binding. 
Mutations within the signaling pathway (besides the receptor) can also mediate a 
sustained proliferative response in cancer cells independent of growth factor stimulus. 
For example, Ras is a known downstream signaling protein in the receptor mediated 
pathway and one in four (25%) of all human tumors have the mutant Ras gene switched 
on36. 
1.2.2. Metastasis 
In cancer, a solid tumor cannot expand and spread without a series of synchronized 
events. Metastasis is a multistep process that encompasses the modulation of basement 
membrane permeability at the tumor site; decreased cell attachment, tumor cell invasion, 
cell migration and proliferation in response to survival and pro-angiogenic signals.37 
Though the classical belief regards metastasis as a late event in cancer progression, it is 
acknowledged that metastatic signaling events can be initiated during early tumorigenesis 
and progression. Specifically, cell origin and oncogenic alterations influence the 
molecular characteristics of a tumor and its malignancy potential.134  
While the metastatic potential is relatively small for tumor cells, there is an epigenetic 
influence that leads to the transformation from non-metastatic to aggressive tumor 
cell37,53. It is not a passive event where cancerous cells are sloughed off a tumor and 
shuttled to distal sites for colonization. On the contrary, it is a highly active process that 
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involves chemotactic signals that drive cell motility, release of proteases and other 
enzymes that degrade the extracellular matrix (ECM), avoidance of the immune response 
and apoptotic, anoikis and amorphotic signals, unresponsiveness to growth inhibitory 
signals and as mentioned earlier, growth factor independent proliferation53,117. 
Furthermore changes in cell adhesion molecules (integrins, cadherin-catenins) and 
protease expression have been linked to tumor invasion and metastasis1,122. Within recent 
years, interest has been generated regarding the role of endocytosis in tumor progression 
and metastasis, particularly the trafficking of metastatic factors that mediate two of the 
necessary stages that characterize metastasis; cell migration and cell invasion.67,97,122 
1.2.3. Characteristics of Invading cells 
Cell migration and invasion are key components of metastasis where atypical 
epithelial cells have acquired phenotypic changes that mediate the spread of the cancer to 
distant tissues and organs.  Cell migration is a highly regulated event and is controlled by 
the expression and localization of specific cell surface receptors, such as Integrins, 
Epithelial Growth Factor (EGF)- Receptor (EGFR), Insulin Growth Factor (IGF)- 
Receptor (IGFR), the reorganization of cytoskeletal elements, and the directed trafficking 
of molecules required for cell signaling and adhesion.8,110  
There are three distinctive types of morphologic events that are affiliated with early 
metastasis- epithelial mesenchymal transition (EMT)71,147, collective invasion41,42 and 
amoeboid transcription85,115. Most recently a fourth concept, inflammatory induced 
invasion, has been identified as another morphogenic episode in metastasis64,93,106. 
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1.2.3.1. Epithelial Mesenchymal Transition  
The most common of the morphogenic episodes associated with metastasis, EMT is a 
process where cells elongate, secrete ECM proteases which degrade the matrix and 
migrate out53. Transforming Growth Factor β (GFβ) induces EMT via RAS-GTPases 
signaling102 and facilitate changes to a more invasive phenotype in cancer cells in 
response to ligand growth factor stimuli, specifically IGF-1133.  Within the human body, 
tissue is comprised of two types of cells that aggregate and perform a specialized task; 
epithelial cells and mesenchymal cells. Epithelial cells are atypical in shape, adherent to 
other cells to form layers within the tissue; of which the latter is interspersed with 
structural carbohydrates and proteins that serve as the extracellular matrix. Mesenchymal 
cells are solitary cells that possess a strong migratory potential. Yet most cancers (at least 
90%) are epithelial in origin127.  
Normal epithelial cells secrete E-cadherin, a regulatory protein that maintains adhesive 
(glue-like) structure between the cells and suppresses the release of pro-migratory growth 
molecules thereby ensuring that the cells remain in senescence and contact inhibition. 
With the advent of metastasis, E-cadherin function is lost and there is a gradual shift to 
N-cadherin expression; which is expressed in migrating cells.133  After EMT, motile cells 
migrate mesenchymally where they extend projections called lamellipodia on the front of 
the cells while binding to specific surface cell surface receptors such as beta-
integrins19,147.  This movement is largely regulated by several small GTPases like H-
RAS, N-RAS, K-Ras, Rac1, Rho and Cdc42  GTPases activity138.  
Actin dependent contractile  propulsion push the cell body forward while rear is 
released and integrin signaling engage the secretion of matrix metalloproteinases 
6 
(MMPs); degrading the ECM and generating gaps for cells to pass through. EMT cells 
are therefore self- directing and path-generating given the cells’ proteolytic activity as 
they migrate.142  
The most unique aspect of EMT and tumor cell migration is the ability to survive 
without normal matrix components and the evasion of anoikis or adherence to foreign 
ECM as they move34.  
1.2.3.2. Amoeboid Transcription 
Typically aggressive, motility in amoeboid transcription (AT) differs from EMT 
where protease- independent elongated cells acquire a spherical shape and then are 
deformed upon passage through interstices already present in the ECM115. Within AT cell 
migration and invasion is controlled by the Rho family of GTPases109,131.  
Unlike mesenchymal migration, suppression of Smurf1 influences RhoA activation, 
and initiates a signaling cascade that effect the generation of the spheroid structure and 
locomotion. 135 The high metastatic capacity of amoeboid transcription can be attributed 
to the tumor cells’ competence in warping the collagen bed in the ECM which allows the 
cells to become invasive145. 
1.2.3.3. Collective Invasion 
As the name implies, this type of invasion involve the movement of a group of cancer 
cells to neighboring tissues and organs. However, unlike EMT and amoeboid 
transcription, this type of invasion is somewhat controversial and believed to be less 
aggressive as it lacks key characteristics that facilitate metastasis.  
7 
On one hand, it is believed that during collective invasion, cells on the leading edges 
of the collective invasion zones may acquire partial EMT–like traits and drive the 
intravasation process26.  For example, cancer cells expressing high levels of basal 
epithelial markers such as cytokeratin 14 and p63 led invasion of the collective group of 
cells in different subtypes of breast cancer26.  Stromal fibroblasts via Rho activation also 
initiate collective invasion in cancer cells47.  
The other theory is that a unique mechanism distinct from EMT, may be utilized by 
tumor cells undergoing collective invasion39.  
1.2.3.4. Inflammation Induced Invasion 
If EMT can be viewed as a simplistic feature of tumor cell invasion and amoeboid is 
the aggressive, complicated version, inflammation induced invasion can be the product of 
the aforementioned invasive processes. The crosstalk between the stroma and tumor cells 
in the microenvironment influence the invasive potential of tumor cells. In breast cancer, 
it was determined that cancer cells signaled the secretion of chemokines by mesenchymal 
cells located in the stromal bed, and these chemokines stimulate cancer cells to become 
aggressive and invasive65.  
Immune cells at tumor sites enable invasion by supplying MMPs. Tumor associated 
macrophages (TAMs) furnish cancer cells with growth factors and cancer cells 
reciprocate by providing colony stimulating factor 1 (csf1) thereby driving increasingly 
invasive behavior in tumor cells112. 
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1.3 Growth Factor Driven Signaling in Tumor Metastasis 
Metastatic factors such as HGF, EGF, TGFβ and IGF are known to activate the 
endosomal pathway and the mechanisms can be analogous at key junctions thereby 
promoting a migratory response in tumor cells.   
These Receptor Tyrosine Kinases (RTKs) can be internalized through two principal 
pathways: clathrin coated pits or caveolae. We will briefly discuss a few of these growth 
factors and their possible roles in early endocytic trafficking and tumor progression. A 
detailed review of most metastatic growth factors (whether mentioned here or not) with 
the exception of IGF-1 can be accessed from the following reference.61 
1.3.1. Epithelial Growth Factor 
Perhaps the most studied and understood receptor trafficking systems, EGFR signaling 
is a crucial aspect of breast cancer metastasis11,15,38,88,90. Epithelial Growth Factor 
Receptor signaling is heavily regulated by endocytosis where EGF triggers the 
internalization of the EGFR complex via clathrin-mediated endocytosis57,123, clathrin-
independent mechanisms104and subsequent activation of the mitogen-activated protein 
kinases (MAPK) signaling pathway. 
The Arf GAP with Rho GAP domain, ankyrin repeat, and PH domain 1 (ARAP1) 
protein controls EGFR trafficking via Rab5 activation and affect the rate of EGFR signal 
attenuation 149 and ensuing MAPK signaling. A recent study highlighted the role of 
clathrin-mediated endocytosis  Epithelial Growth Factor directed chemotactic invasion of 
breast cancer98.  Rab5a is characterized as a significant molecule in ovarian cancer upon 
EGF stimulation.155  
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On the other hand, Rab5c has been implicated in EGFR signaling by affecting integrin 
recycling and triggering cell invasion in some breast cancer cells.103 Rab11a is known to 
modulate EGFR recycling and have a differential effect on proliferation and motility of 
MCF10A breast cells.107  Inhibition of Rab35 fostered a shift from epithelial to 
mesenchymal status, and led to an increase in cell migration and invasion in tumor cells 
in response to EGFR activation. 3  
 
 
1.3.2. Hepatocyte Growth Factor 
It has been previously reported that HGF signaling involves the activation of the 
Hepatocyte Growth Factor Receptor (MET) and the receptor undergoes rapid endocytosis 
via clathrin dependent and independent endocytic pathways.  
Hepatocyte Growth Factor Receptor trafficking requires Rab5 and facilitates focal 
adhesion turnover, actin remodeling and sustained MAPK signaling thereby underscoring 
its role in tumorigenesis, cell migration and invasion. 52 Further studies show that human 
growth hormone (HGH) exposure in cells expressing naturally occurring Met mutants 
boosted endocytic activity and led to tumor metastasis.61 
1.3.3. Transforming Growth Factor β 
The TGFβ has an interesting dual role in cancer.  As indicated earlier, metastasis 
necessitates the transformation from epithelial cell to mesenchymal cell phenotype. 
During this process, TGFβ has been characterized in its role in epithelial 
mesenchymal transition (EMT) and tumorigenesis as having both a positive and 
negative influence in the promotion of cell migration and invasion.29  
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The TGFβ signaling involves the internalization of the Transforming Growth 
Factor β Receptor (TGFβR) through clathrin dependent and independent pathways 
and was found in EEA1 and caveolin positive vesicles, respectively.31 Furthermore, 
the intensity of TGFβ was sustained through recycling of the receptor through ligand 
stimulation and clathrin internalization though Rab11 irrespective of ligand 
activation via Rab4 activity91. 
 It was also noted that lipid raft-caveloar induced rapid receptor turnover by the 
competitive binding of the internalized TGFβR with a small intracellular inhibitory 
protein, mothers against decapentaplegic homolog 7 (Smad7) coupled with SMAD 
specific E3 ubiquitin protein ligase 2 (Smurf2); of which this Smad7-Smurf7 complex 
tags the TGFβR for degradation31 through the proteasomal or lysosomal pathways.  
While there is a dearth of information regarding the direct involvement of TGFβR 
endocytosis in cancer metastasis, it was recently reported that delayed endocytosis of the 
TGF-βRII was due to a gain-of-mutation of the receptor and enhanced TGF-β signaling. 
This resulted in a more invasive phenotype of human oral squamous carcinoma108. 
1.3.4. Insulin Growth Factor 
The IGF system is a complex highly regulated network and its influence in cancer has 
been extensively reviewed by several groups 6,14,17,77,82,116.  Here, the key features of IGF-
1 and the downstream effectors in cancer biology is recapitulated. The IGF-1 system is 
comprised of the IGF ligands (IGF-1 and IGF-2), cell-surface receptors that mediate the 
biological effects of the IGFs, including the IGF-1 receptor (IGF-1R), the IGF-2 receptor 
(IGF-2R), the insulin receptor (IR), as well as a family of IGF-binding proteins 
(IGFBPs). 
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Most IGF-1 in circulation is produced by the liver, and IGF-1 synthesis and action is 
linked to the growth hormone (GH) system, typically referred to as the GH/IGF axis70. 
IGF-1 is also synthesized in other organs and tissue where autocrine and paracrine 
mechanisms are essential. Insulin Growth Factor-1 activity is modulated in part by 
IGFBPs, where close to 99% is bound, leaving a small percentage to exert its influence 
on the body51. 
Insulin Growth Factor-1 signaling may be both IGF-1R dependent or independent. 
Insulin Growth Factor  signaling is initiated by the binding of the IGF-1 or IGF-2 ligand 
to the IGF-1R/ IGF-2R and the subsequent phosphorylation of tyrosine residues of 
specific cytosolic kinase domains35,82,111. 
The activated receptor transduces this phosphorylation activity to insulin receptor 
substrates (IRS) and Shc adaptor proteins; and starts a signaling cascade that involves the 
MAPK and phosphatidylinositol 3-kinase (PI3K) intracellular signaling pathways that are 
responsible for the diverse target actions of these growth factors, which include increases 
in cell division, cell size, protein synthesis, cell migration, and inhibition of apoptosis78. 
Many of the signaling elements that are downstream from tyrosine kinase activation have 
been characterized, but several of the molecular events (such as the possible 
internalization of the receptor) that may occur before or concomitantly with kinase 
activation and whether these early events can influence the ultimate outcome of IGF-1-
stimulated signal transduction have not been determined. 
The IGF system is integral to a number of cellular processes ranging from normal 
growth and development of specific organs, such as in the nervous system, in 
which IGF signaling regulates neuronal proliferation, apoptosis, and cell survival82,111,116. 
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Conversely, IGF also has a critical role in pathological situations, particularly 
tumorigenesis and a growing body of epidemiological studies has implicated free IGF-1 
serum levels as a risk factor for the development and progression of breast, prostate, 
colon, and lung cancer35,46,111. The adverse effect of IGF is unsurprising given the 
delicate balance that must be maintained, and the diverse and extensive regulatory 
function of IGF-1 in maintaining homeostasis. 
 Insulin Growth Factor-1 does not induce mutations but may promote cancer via the 
apoptotic pathway as it is a survival factor similar to PDGF, EGF and act via the IGF-1R 
to stimulate the phosphatidylinositol 3-kinase PI3K /Akt pathway49,78. Kurmasheva et al. 
maintained that the IGF-1 mediates cell survival in adverse physiological conditions 
ranging from oxidative stress, low nutrient, cytoxic or hypoxic environments.74 Insulin 
Growth Factor-1 facilitates cell survival by regulating the expression of pro- and anti-
apoptotic proteins.  Specifically, IGF-1 binding to the IGF-1R ligand induces the 
activation of Akt which phosphorylates the pro-apoptotic protein Bad78. This 
phosphorylation activity in turn, induces a conformational change in Bad and inhibited its 
interaction with the anti-apoptotic Bcl proteins and the subsequent activation of the 
caspase chain thereby allowing the transformed and pre-cancerous cells to escape 
apoptosis and survive.  
Insulin Growth Factor-1 has been demonstrated to increase VEGF expression of tumor 
cells and inhibit apoptosis by binding to caspase 9 which is unable to cleave caspase 3 
and halting the caspase cascade to apoptosis132. It is known that IGF-1 protect scells from 
anoikis which is a process that ensures cells undergo apoptosis when they are detached 
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and no longer able to adhere to the extracellular matrix and this protective action may be 
conferred to pre-metastatic tumor cells.  
Insulin Growth Factor-1 levels increase in response to ECM degradation by matrix 
metalloproteinases (MMPs) and ensure the survival and hyperproliferative state of 
cancerous cells.128 Insulin Growth Factor-1 increases the pro-metastatic property of 
cancer cells by reorganizing integrin receptors, and modulating the E-cadherin/ β-catenin 
complex which in turn, increase MMPs expression and the migratory potential of the 
cells133  β-catenin as a result, accumulates in the nucleus (possible translocation from 
cytoplasm), and there is an increase cell proliferation by inactivation of glycogen 
synthase kinase 3B (GSK3B)30.  
Insulin Growth Factor-1 also facilitates the crosstalk between the PI3K and MAPK 
pathways via Ras (upstream effector of the p85subunit of PI3K) which potentiates both 
the cell proliferation and cell survival cell response. Some interesting studies that 
proffered other links between IGF-1 and cancer where an inverse relationship exists 
between the tumor suppressor genes p53 and Wnt1 and low expression of the genes was 
dominant in highly aggressive breast cancer cells (estrogen receptor negative; ER-)35. 
It is now known that that circulating IGF-1 levels are higher in breast cancer patients 
compared with normal controls 111 while high IGF levels are associated with increased 
risk of breast cancer in pre-menopausal women.54  
There also exists an inherent relationship between IGF-1 and estrogen (E2). Estrogen 
has been shown to increase IGF-1 and IGF-1R expression and transcription, with the 
latter having a positive feedback and activating the IGF-1 signal pathways35. 
Furthermore, it has been determined that the E2 antagonist, tamoxifen and other 
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antiestrogens suppress IGF-1 gene expression and MAPK and PI3K pathways.27  
Conversely in tamoxifen resistant cancer cells, IGF-1R expression as well as MAPK 
phosphorylation were activated in tamoxifen resistant cancer cells87. 
1.3.4.1. IGF-1R and Endocytosis 
Despite the limited information regarding the function of endocytosis in IGF-1 driven 
tumorigenesis, recent evidence points to an increase in cell proliferation and inhibition of 
apoptosis upon IGF-1R stimulation and ensuing internalization and co-localization with 
clathrin and caveolin-1 in Ewing sarcoma cells.86 Insulin Growth Factor-1 receptor is also 
localized in the nucleus in prostate, renal and breast tumor cells after translocation from 
the cell surface via clathrin mediated endocytosis.2 Whether early endocytosis of IGF-1R 
is key in regulating tumorigenesis and cancer metastasis remains to be seen. 
1.4. Endosomal Signaling and Intracellular Trafficking 
Within a cell, homeostatic conditions and normal cell mechanisms and processes such 
as differentiation, cell migration, proliferation, gene transcription, vesicular trafficking, 
cytoskeleton modulation and organization and nuclear assembly are tightly regulated and 
rely heavily on the small GTPase activity.83,139 These monomeric GTPases are 
homologous to the heteromeric G-proteins where they hydrolyze the active bound form 
of GTP to the inactive bound form thereby acting as molecular switches66 and cycling 
between the active GTP and inactive GDP bound forms via three classes of regulatory 
proteins: the GTPase activating proteins (GAPs), guanine nucleotide disassociation 
inhibitors (GDIs) and guanine exchange factors (GEFs)18. 
One of the largest sub-families of the large Ras superfamily of small GTPases is the 
Rab proteins153. They extend across more than 60 members in mammals and are highly 
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conserved from yeast to humans. The Rab family of proteins plays important regulatory 
roles in vesicle formation and transportation from plasma membrane to various 
organelles within the cell through the recruitment of small factors that include 
phosphatases, kinases and docking , adaptor proteins as well as actin filaments and 
microtubules in cell migration and mitosis.126   
In this way, given the myriad of functions that Rab proteins regulate during 
intracellular trafficking, it is unsurprising that there is a marked interest in Rab GTPase 
function and expression in tumor progression. The Rab proteins have been specifically 
linked to the deregulation of several signaling pathways in several cancers and also been 
implicated in the promotion of abnormal proliferation, migration and invasion of 
epithelial cells in tumor progression because of stimulation of membrane bound growth 
factor receptors23.  
Disruption of endocytosis confers growth factor and ECM self-sufficiency to cancer 
cells as discussed earlier, imparts growth factor and extracellular matrix autonomy to 
cancer cells by bypassing key endocytic processes such as lysosomal degradation and 
instead promote the recycling of growth factors as well as integrins. In response to this  
deviant endocytic pathway, cellular processes such as adhesion, migration, proliferation, 
polarity, asymmetrical division and overall survival are modified and represent emerging 
hallmarks of cancer92. 
1.4.1. Differential Expression of Rab GTPases in Cancer Cells 
Though the functional role of Rab GTPases have not been fully characterized in 
cancer cells, studies have shown that at the genomic levels, there is a deregulated 
expression of Rab in tumor cells which also differs within specific tissue.  
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The GTPase, Rab23, is over-expressed in bladder 58, gastric 59 and ovarian 24 
carcinoma whilst it is purported to be down-regulated in triple negative breast cancer21,22. 
Similarly Rab25 have differing expression levels with increased expression in estrogen 
and progesterone receptor positive breast cancer 148 and suppression in colon and head 
and neck tumors5,100. 
Down-regulation of Rab38 may be associated with metastasis in melanoma95. In 
gastric cancer, other Rabs have been implicated such as Rab32, Rab34 and Rab40C of 
which hypermethylation of the Rab32 gene led to down-regulation in the tumor 120 and 
conversely suppression of specific miRNAs; miR-9 and let-7a promoted the efflux of 
Rab34 and Rab40c expression84. 
Likewise, alterations in miRNA expression (specifically miRNA-451 and miRNA-
101) led to non-small lung cancer via  over-expression of Rab14 137 and upregulation of 
Rab5a in hepatocellular carcinoma, 119 respectively. Furthermore in highly metastatic 
lung cancer, post-translational modifications and in increase in gene expression mediated 
elevated Rab37 and Rab7 levels. 99,143 In liver cancer, Rab1b, Rab4b, Rab10, Rab22 and 
Rab24 are over-expressed 55 whilst Rab1a is higher than normal in tongue cancer121. 
It is also known that Rab2B levels are elevated in colon carcinoma101 while in thyroid 
associated adenomas, Rab5a and Rab7 are upregulated75. Breast cancer metastasis and 
worse outcomes in patients have been attributed to high levels of Rab31 and Rab5a72,146. 
1.4.2. The Role of Rab GTPases in regulating Cell Migration 
As mentioned earlier, one of the key characteristics of metatastic cells is the ability to 
migrate and invade through a compromised ECM and translocate to distal sites, thereby 
forming secondary tumors or metastases53.  
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Rab35, a gtpase involved in Rho mediated actin cytoskeletal reorganization, is 
upregulated in migrating breast cancer cells in response to Wnt activation. Chau et al. 
demonstrated that actin dependent protrusions were generated by Rab35 acting on Rho 
GTPases28. The silencing of Rab35 inhibited cell migration in MCF7 breast cancer 
cells.157 Conversely, Rab35 mitigates cell migration in brain tumor cells 3 which suggest 
that Rab GTPase modulation of cell migration may be tissue specific. 
Similarly Rab25, a protein that plays a critical role in translocating and recycling 
integrin and other pro-migratory factors from endosomes to the plasma membrane have 
contrary actions on cell migration. In esophageal squamous cell carcinoma (ESCC), Rab 
25 was characterized as a tumor suppressor as diminished Rab25 expression was seen as 
poor prognosis for esophageal cancer survival by enhancing migration and invasiveness 
of cancer cells.129  Interestingly, it has also been shown that loss of Rab25 (function or 
expression) increased turmorigenesis in mammary epithelial cells22. However, Rab25 is 
also said to be an oncogene given its  role in advanced stages of ovarian and breast 
cancers and is linked to an increase in malignancy and migration of the epithelial cells by 
modulating cell proliferation (both anchorage dependent and independent cells), 
trafficking of integrin and suppressing apoptosis24. Specifically, Rab25 promotes cell 
survival by increasing PI3K signaling through the interaction with the Rab-coupling 
protein which in turn sustains the recycling of both EGFR and the fibronectin receptor 
(integrin α5β1). It was determined that Rab25 accelerates cell migration by actively 
moderating the recycling of integrins via the chloride intracellular channel protein 3 
where this process is required in the freeing of the  cell’s rear in cell migration and 
invasion33. 
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 Both Rab25 and Rab11 overexpression augmented the pace of cell migration by 
affecting small-scale fast recycling within the tips of the cell and basal long-distance 
transport from the rear end to the front of the migrating cell basal long-distance transport 
from the rear end to the front of the migrating cell respectively in HeLa and MDA-MB 
231 cell lines69. 
A GTPase essential for early endosomal formation and trafficking, Rab5, is involved 
in lamellipodia formation and actin remodeling in response to growth factor stimulation 
105,124 and this may be attributed to tyrosine signaling and subsequent activation of Ras 
and Rab5 GAPs10,76.  
Rab5 is expressed differentially in cancer cells where Yu et al. identified Rab5a as a 
potential major factor in the transformation of tumor cells in human lung 
adenocarcinoma, to an aggressive phenotype where overexpression of Rab5a was 
associated with increasing metastatic capacity.151 The loss of Rab5a expression in HeLa 
and SiHa cells significantly suppressed or abrogated cancer cell motility and also down-
regulated Rho A expression80 whereas Rab5a overexpression  elevated the proliferative 
activity of ovarian cancer cells155. 
Studies in flies (Drosophila) and mouse neurons have shown that cell migration can be 
mediated by endocytotic and trafficking mechanisms and dependent on Rab5 and Rab11 
expression in epithelial cells68,118. Migration of cells in hepatocellular carcinoma was also 
dependent on VEGF/PDGF (platelet derived growth factor) and EGFR mediated tyrosine 
kinase endocytosis via Rab5 44, hepatitis B induced Rab5 expression 119 and Rab1162,63. 
Actin remodeling and cell migration are dependent on Rac activity which is trafficked by 
Rab5 and affects the internalization of integrins during cell migration130,152.  
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Lysosome trafficking is an important feature of the endocytic pathway particularly in 
the degradation growth factor receptors and / or ligands and is regulated by Rab7125,140. 
Disruption of the endocytic pathway in EGF mediated signaling in cancer cells can be 
rescued by the activation of the autophagy and lysosomal pathway. A tumor suppressor 
and Bax family member, Bif1, led to the recruitment of Rab7 to the early endosome and 
facilitated the loss of cell migration of breast cancer cells by directing the degradation of 
the EGFR114.  
 
 
Rabs Cancer Type Location Cell Function 
Effect on Cell 
Migration or 
Invasion 
Refs 
Rab4a 
(invasion) 
melanoma plasma membrane protein transport secrete 
procathepsin-L, 
translocates furin   
 
 
9 
Rab5a 
(invasion) 
cervical, breast Plasma membrane, 
Early endosome, 
Melanosomes 
Fusion of PM to 
EE, protein 
transport 
down-regulation of 
integrins, Rac1, 
CDC42, reduction 
in number of 
lamelipodia, 
transport of MT1-
MMP and β3 
integrin 
 
 
 
43,81 
Rab5a 
(migration) 
hepatocellular 
carcinoma, breast 
plasma membrane, 
early endosome 
Translocation of 
surface receptors 
to late endosome 
lamellipodia 
formation and 
actin remodeling in 
response to growth 
factor stimulation  
21,45,89,119,146 
Rab7 
(invasion) 
liver, prostate  Late endosome, 
Lysosome, 
Melanosomes 
Late endocytic 
transport 
decrease protease 
secretion 
 
 
125,140 
Rab7 
(migration) 
breast, liver  late endosome, 
lysosome 
exocytosis, late 
endosome 
  
114,140 
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Rab8 
(invasion) 
 
lung adenocarcinoma plasma membrane vessicle trafficking  secretion and 
cleavage of (MT1-
MMP 
 
 
16 
Rab11 (a,b,c) 
(invasion) 
breast, colon, lung, 
ovarian, renal, 
endometrial, prostate, 
bladder and carcinoid 
types 
recycling endosome Long loop 
recycling 
down regulates E-
cadherin 
 
 
150,156 
Rab11 (a,b,c) 
(migration) 
breast, colon, lung, 
ovarian, renal, 
endometrial, prostate, 
bladder and carcinoid 
types 
recycling endosome long loop recycling  stabilization of 
microtubules 
20,48,69 
Rab23 
(invasion) 
gastric cancer 
 
 
Plasma membrane vessicle trafficking    
60 
Rab25 
(invasion) 
colon, ovarian, head 
and neck 
apical recycling 
compartment 
integrin recycling recycles integrins 
to psuedopodial tip 
of invasive cells,  
interact with 
CLIC3 (chloride 
intracellular 
channel protein 3) 
to recycle integrins 
from late 
compartment to the 
rear of migrating 
cells 
 
5,24,73 
Rab25 
(migration) 
breast, pancreatic , 
ovarian  
apical endosomes integrin recyling sustained recycling 
of intergrin and 
growth factor 
receptors 
22,24,33,69,129 
Rab27a,b 
(invasion) 
glioma, breast, liver Plasma membrane, 
melanosomes 
exocytosis secrete IGF-2, 
MMP2 activation 
 32,56,94,136,144 
Rab31 
(invasion) 
metastatic breast  Plasma membrane, 
transgoli network 
anterograde 
transport  
reduced adhesion 
to extracellular 
matrix proteins 
50 
Rab35 
(migration) 
breast, brain sorting and recycling 
endosome tubules 
 
 recycling activate Rho 
GTPases, actin 
dependent 
protrusions, 
increase recycling 
rate 
3,28,157 
 
Table 1: Papers demonstrating some of the Rab GTPases including their function in 
the promotion of cell invasion of tumor cells. 
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1.4.3. The Role of Rab GTPases in Cell Invasion 
Cancer cells attain an array of invasive and malignant phenotypes which are tumor 
and/or site specific 40 and involve a variety of Rab proteins that have been implicated in 
the transition to metastasis where tumor cells become invasive and penetrate the basal 
cell membrane and the ECM. These tumor cells secrete an array of proteases such as 
MMPs, induce the compromised basement membrane to further release more proteases 
such as collagenase and growth factors, thereby allowing cancer cells to breach the basal 
membrane and migrate to distal sites.  For example, it has been ascertained that Rab8 
facilitates cell invasiveness in breast cancer cells at peripheral invasive structures16. 
Further evidence of Rab7 as possible tumor and metastasis suppressor was illustrated 
by Steffan et al125. Silencing of Rab7 expression has a diminutive effect on invasion and 
when Rab7 was present, lysosomes were directed away from cell surface, thereby 
decreasing protease secretion and metastatic capacity of prostate cancer cells125.  
Rab7 has also been associated with MT1-MMP secretion and the promotion of cell 
migration and invasion, where the dominant-negative mutant of Rab7 impairs both 
processes 140. On the other hand, early stage melanomas promoted tumor progression via 
Rab7 regulation of the lysosomal pathway, where high expression of Rab7 was an 
indicator of the high metastatic risk (increased proliferative and invasive outcome) in 
patients4. The contrary role of Rab7 may be attributed to cancer type, stage and specific 
growth factor stimulus. 
Under hypoxic conditions within the tumor microenvironment, Rab11 maintained the 
stabilization of microtubules via the inactivation of GSK3-B and possible down 
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regulation of E-cadherin, which led to an increase of cell invasion of breast cancer 
cells150,156. 
Caswell and colleagues established that Rab25 interaction with α5β1 integrin was 
essential in ovarian epithelial tumor cell invasion into a 3 dimensional (3D) fibronectin-
enriched ECM and may additionally regulate MMP-dependent regulation16,20. Rab 
coupling protein (RCP), an effector of Rab11 and Rab25, acts as an oncogene as it 
promotes breast cancer transformation154. It is also purported that the invasive potential 
of cancer cells is augmented in RCP mediated recycling and signaling of the EGFR and 
integrin, downstream of a mutant form of p5396. 
 Poor prognosis in invasive breast cancers are associated with Rab27 a and b isoforms, 
which are secretory GTPases that control vesicle exocytosis and secrete critical 
proinvasive growth regulators into the tumor microenvironment. Inhibition of Rab27 
activity reduced tumor growth and dissemination of lung carcinoma in response to 
neutrophil mobilization that were in turn, dependent on Rab27 exosomal secretions13.  
In primary hepatocellular carcinoma and lymph node metastasis, Rab27b is over-
expressed 32, and in ER+ breast cancer, Rab27b activates MMP2 through heat shock 
protein (Hsp) 90a secretion and stimulate invasion of breast cancer cells56,94. Rab27a is 
involved in the exocytosis of endocrine cells and conferred an invasive and metastatic 
phenotype by inducing the secretion of IGF-2 in breast cancer cells136.  
The rate of IGF-2 secretion by Rab27 influenced the expression other growth factors 
such as VEGF into the tumor microenvironment, as well as MMPs, such as MMP-9, 
cathepsin D and the cyclin dependent kinases (CDK16)136. It was also suggested that 
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Rab27 may act as an oncogene given its regulatory role of invasive growth and metastasis 
in breast cancer cells and association with poor prognosis in humans56. 
Like a few other Rab GTPases, such as Rab25, Rab27 have dual roles in 
tumorigenesis and can be said to be context dependent. While the studies outlined 
indicate a pro-tumorigenic and metastatic role of Rab27, a study by Li et al indicated that 
Rab27 may possess more anti-tumor characteristics and demonstrated in a  mouse 
model  in vivo, that immunization of exosomes derived from Rab27a-overexpressing 
cells suppressed tumor growth. Analysis of the mice spleens also revealed high levels of 
type 1 cytokines, interleukin-2 (IL2) and IFN-y, in response to Rab27 generated 
exosomes. These cytokines are crucial in the regulation of anti-tumor immunity79. 
 Rab23 also influences cell invasion in two distinct tumor types within gastric cancer, 
where silencing of Rab23 abrogated such activity60. On the other hand, Rab31 
overexpression engendered a shift from a highly invasive capacity to a less invasive and 
highly proliferative phenotype in an experimental mouse model50.   
Rab4 has also been implicated in the secretion of  procathepsin-L, another significant 
protease required in the modulation of the tumor microenvironment where suppression of 
Rab4 expression led to a reduction of tumor mass.9 Growth factor stimulated breast 
cancer cells overexpressing Rab5a affected Rab4 and RABENOSYN-5-dependent 
endo/exocytic cycles in the ferrying of the matrix protease, MT1-MMP and β3 integrin43. 
This trafficking cycle produced a chemotactic dependent invasive and proteolytic 
mesenchymal response in breast carcinoma cells in vitro and in vivo43. Under hypoxic 
conditions, increased cell invasion of tumor cells was also mediated by Rab4 dependent 
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recycling and translocation of furin, which interacts with the cytoskeletal protein filamin 
A at the cell surface.7 
 
 
1.5. Conclusion 
As the role of growth factor driven endocytosis in metastasis is slowly being 
characterized, part of the struggle that currently exists involves the correct identification 
of the crucial endocytic molecules that may be potential therapeutic targets in cancer 
treatment. These may include but not limited to Rab5, and its effectors the GEFs such as 
Rab interactor 1 (RIN1) and GTPase Activating Proteins (GAPs). As outlined lined 
above, there is a paucity of research specifically regarding the relationship between Rab 
GTPases and growth factors, particularly IGF-1, in cancer cell migration and invasion.  
Whilst most Rabs are currently not considered to be oncogenic, there is growing 
evidence that may suggest otherwise. Endocytosis is an indispensable signaling 
mechanism in growth factor induced signaling, it is worth considering the early factors 
such as Rab5 that exert a great influence on intracellular trafficking and also as a 
coordinator in the crosstalk amongst signaling pathways in the propagating and 
promoting metastasis (Fig 2). 
Further description of Rab function in cancer cell metastasis would be beneficial as 
these Rabs can be prospective biomarkers in determining cancer stage and outcome 
prognosis. This opens the doors to the development of new therapeutic methods to target 
these necessary proteins such as siRNA or peptide manipulations that can selectively 
affect Rab effectors.   
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1.6. Thesis Overview 
This project aims to examine the trafficking and signaling pathways involved in the 
progression from dormant tumor cells to aggressive invading cells via Rab5 GTPase 
activity and interaction with IGF-1R, and subsequent downstream signal transduction 
pathways.  The hypothesis is that Rab5 GTPase activity is one of the key elements in 
proliferation, migration and invasion of cells in breast cancer mediated by the IGF-
1R. Therefore, specific aims were designed to address this hypothesis.  
For the Aims, it was: 
(I)  to determine whether small Rab GTPases mediate phenotypic changes in 
the promotion of proliferation, migration and invasion activities in breast cancer cells 
in the presence of IGF-1 
(II)  to elucidate the signaling mechanism induced by IGF-1 via Rab5 
function in modulating malignancy of breast cancer cells 
(III) to examine the role of Rab5-Guanine Exchange Factors (GEFs) 
in proliferation and migration of breast cancer cells induced by IGF-1. 
This thesis is divided into 5 chapters.  
Chapter 1 is the INTRODUCTION and literature review. The content of this chapter has 
been submitted for publishing and is currently under-review. 
Chapter 2 elucidates the importance of Rab5, early endocytic membrane protein, as a 
potential mediator of tumorigenesis and metastasis. The Rab5 activity was shown to be a 
modulator of cells invasion and migration of non-aggressive breast cancer cells, MCF7 in 
response IGF-1 stimulation. Further analysis revealed that the guanine exchange factor 
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(GEF) that interacts with Rab5, Rin1, also promotes cells migration and invasion of 
tumor cells. 
Chapter 3 examines the suppression of the aggressive potential of the highly metastastic 
breast cancer cell line, MDA-MB231 in response to IGF-1 and normal growth media. 
Over-expression of the inactive mutant form of Rab5, Rab5:S34N, impaired the invasion 
and migratory activity of aggressive breast cancer cells. Rin1 over-expression also 
mediated a highly aggressive phenotype, while the mutant abrogated cell invasion and 
migration. 
Chapter 4 reveals the effect of inhibition of the IGF-1 receptor and early endocytic 
pathway on cell migration and invasion in MCF7 cells. This study also demonstrates that 
these inhibitors affect downstream signaling proteins and genes: the metalloproteinase 
MMP9, Rab5a and MAPK and PI3K signaling pathways 
Chapter 5 summarizes the relevance and significance of the above research with future 
possibilities resulting from this study. 
 
1.7. Figures 
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Figure 1. EMT-mediated invasion and amoeboid invasion in cancer metastasis. 
TAMs secrete cytokines and growth factors (EGF, TGF, HGF) and primary tumor 
cells respond to growth factor stimulation. These cells (dark in color) undergo EMT 
and invade and migrate into blood or lymphatic circulation. Some tumor cells may 
invade via AT by morphological conformation to spheroids and pass through pre-
existing gaps in ECM. (EMT: epithelial-mesenchymal transition, MAT: 
mesenchymal-amoeboid transition, AT: amoeboid transition, TAMs: tumor 
activated macrophages) 
IGF-1R as a possible target in tumor progression and metastasis 
• Decrease in cell adhesion molecules; 
• Rab5 dependent endocytosis of E-cadherin 
• Up-regulation of mesenchymal markers: N-cadherin, vimentin, smooth 
muscle actin 
• Proteolytic driven 
• Integrin trafficking via Rab5 and Rab4 leading to FA disassembly 
• Growth factor dependent 
• Activation of Rac1/RhoA GTPase switch 
• Spherical transformation and deformation  
• ECM attachment and protease independent 
(pass through existing interstitial gaps) 
• Growth factor independent or dependent
Illustrated by Meifung Su 
28 
 
Figure 2. Illustration of the possible role IGF-1 plays in mediating metastasis in breast 
cancer cells. IGF-1 ligand binds to IGF-1 receptor. The activated receptor is internalized; 
Rab5 is recruited leading to the formation of the early endosome and subsequent launching 
of the downstream endocytic machinery and MAPK pathway. The IGF-1R is later shuttled 
back to the plasma membrane via the recycling endosome (RE), or to the lysosome through 
the late endosome (LE). It is known that IGF-1 can also lead to the transactivation of the 
EGFR 113, internalization of the EGFR and subsequent degradation of the receptor. 
Activation of the MAPK pathway led to the transcription and secretion of 
metalloproteinases such as MMP2 and MMP9, degradation of the basement membrane, 
actin polymerization and reorganization of integrin receptors. 
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CHAPTER 2. 
Insulin-like Growth Factor-1 induces Migration and Invasion via Rab5 Activation 
 
This chapter demonstrates the atypical non-invasive breast tumor cells (MCF7) acquire 
an aggressive phenotype, thereby becoming more proliferative, motile and invasive in 
response to IGF-1. Most importantly, early endocytosis of the IGF-1R regulated by Rab5 
and its GEF RIN1 is implicated in this transition of breast cancer cells. 
2.1 Abstract 
Cell invasion, proliferation and migration are classic indicators of metastasis.  Growth 
factors, while important for normal cellular processes, are also pro-metastatic. In this 
study, it was determined that invasion and migration in non-invasive MCF7 cells was 
regulated by growth factors via Rab GTPases.   It was also indicated that the invasive and 
migratory properties of breast cancer MCF7 cells upon growth factor stimulation were 
abrogated in cell lines that only expressed the inactive (GDP-bound) form of Rab5 
irrespective of growth factor stimulation. The invasive potential of breast cancer MCF7 
cell lines expressing the Rab5WT and active (GTP-bound) form of Rab5 mutant 
(Rab5:Q79L) were noticeably greater when exposed to growth factors. In addition, we 
observed that Rab5 was activated in cells incubated with IGF-1 in a time and 
concentration dependent manner. Therefore, it can be concluded that Rab5 activation 
plays a crucial role in cell invasion, proliferation, migration particularly in response to 
growth factor stimulus. 
2.2 Introduction 
Cell migration and invasion are key components of metastasis where the atypical 
epithelial cells have acquired phenotypic changes that mediate the spread of the cancer to 
46 
distant tissues and organs.  These processes are highly regulated and controlled by the 
expression and localization of specific cell surface receptors, such as integrin receptor, 
EGFR, IGFR; the reorganization of cytoskeletal elements; and the directed trafficking of 
molecules required for cell signaling and adhesion 1,39,49. Therefore it unsurprising that 
cancer cells hijack and utilize these important cellular and biological functions ensuring 
the malignancy and spread of the disease to distal sites. 
Trafficking of signaling molecules and ligand growth factors are regulated by the Rab 
family of proteins. These small monomeric GTPases play important regulatory roles in 
vesicle formation and transportation from plasma membrane to various organelles within 
the cell through the recruitment of small factors that include phosphatases, kinases and 
docking , adaptor proteins as well as actin filaments and microtubules in cell migration 
and mitosis 50.    
Given the myriad of functions that Rab proteins regulate, it is unsurprising that there is 
a marked interest in Rab GTPase function and expression in tumor progression. The Rab 
proteins have been specifically linked to the deregulation of several signaling pathways in 
several cancers and also been implicated in the promotion of abnormal migratory and 
invasion of epithelial cells in tumor progression55,58,63. For example, Rab25 is purported 
to be an oncogene given its  role in advanced stages of ovarian and breast cancers and is 
linked to an increase in malignancy and migration of the epithelial cells by modulating 
cell proliferation (both anchorage dependent and independent cells), trafficking of 
integrin and suppressing apoptosis6. The silencing of Rab35 inhibited cell migration in 
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MCF7 breast cancer cells67, while Rab11 and Rab27 facilitate an invasive phenotype and 
poor prognosis in breast carcinoma15,62,64.   
Rab5, a GTPase essential for early endosomal formation and trafficking, is involved in 
lamellipodia formation and actin remodeling. These physiological changes are in 
response to growth factor stimulation, the recruitment of Rac1 guanine-nucleotide-
exchange factor (GEF) Tiam1 to early endosomes36,47 and these changes may be 
attributed to receptor tyrosine kinase (RTK) signaling and subsequent activation of Ras 
and Rab5 GAPs4,27. Rab5a is expressed differentially in cancer cells where Yu et al. 
identified Rab5a as a potential major factor in the transformation of tumor cells in human 
lung adenocarcinoma, to an aggressive phenotype where overexpression of Rab5a was 
associated with increasing metastatic capacity63.  
Inulin Growth Factor -1 Receptor, a RTK, is involved in cell survival and proliferation 
of both normal and malignant phenotypes60. Insulin Growth Factor signaling is initiated 
by the binding of the IGF-1 or IGF-2 ligand to the IGF-1R/ IGF-2R and the subsequent 
autophosphorylation of tyrosine residues of specific cytosolic kinase domains. The 
activated receptor transduces this phosphorylation activity to IRS and Shc adaptor 
proteins, and starts a signaling cascade that involves the MAPK and PI3K intracellular 
signaling pathways that regulate cell survival and proliferation. RTKs can be internalized 
through two principal pathways: clathrin coated pits or caveolae. The IGF-1R is 
internalized via both pathways7 and this may have a significant pathological effect in 
tumor progression. 
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The inherent relationship between Rab5 and IGF-1 in metastasis is more than implied 
despite the paucity of data establishing a clear link. As it currently stands, research have 
both alluded to IGF-1 involvement in endocytic pathway and the consequent activation of 
down signaling molecules 16,42. The present study investigated Rab5 activity in response 
to IGFR activation in breast cancer.  
Here, it has been determined that Rab5 expression was closely related with increased 
cell migration and invasion of MCF7 breast cancer cells. Furthermore, the guanine 
exchange factor, the Rab5 interfering 1 (RIN1), also induce breast metastasis through the 
enhanced endocytosis of the IGF-1R. 
2.3 Materials and Methods 
2.3.1 Cell Culture and Materials:  
The MCF7 cells were grown in Dulbecco’s Modified Eagle’s medium (DMEM) 
supplemented with 10% (w/v) fetal bovine serum, 2 mM L-glutamine, 100 U/ml 
penicillin, and 100 μg/ml of streptomycin. The antibodies for EEA-1 and Rab5 were 
purchased from Cell Signaling Technology (Beverly, MA). RIN1 antibodies were from 
Abcam Inc. and secondary antibodies were obtained from Jackson ImmunoResearch 
Laboratories (West Grove, PA). IGF-1 was purchased from Novus Biologicals (Littleton, 
CO) .Other chemicals were obtained from Sigma unless otherwise stated. 
2.3.2 Construction of recombinant pMX-puro retroviruses and cell lines 
As previously described, the cDNAs of Rab5 and RIN1 were subcloned into the pMX-
puro vector 3.Transfection of 60% confluent  PhoA cells was perfomed using Fugene 
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(Roche) and the virus harvested after 48hrs post-transfection. MCF7 cell line was 
infected with the retrovirus tagged with green fluorescent protein (GFP) and Rab5, RIN1 
and control cell lines were generated and selected after 72 hrs.  
2.3.3 EEA1 pull-down assay 
The MCF7 cells were lysed using a lysis buffer containing 20 mM HEPES (pH 7.5), 100 
mM NaCl, 1 mM DTT, 5 mM MgCl2, 5% (v/v) glycerol and 1% (v/v) Triton-X-100 
supplemented with 1 mM PMSF. Lysates (1 ml) were then incubated with 100 μl of 
glutathione beads containing ~10 μg of GST-EEA1 at 4°C while rocking for 1 hr. After 
incubation, the beads were washed three times using the lysis buffer. The pull-downs 
were subjected to SDS-PAGE and analyzed by immunoblotting using an anti-Rab5 
antibody. 
2.3.4 Cell Migration and Invasion Assays 
Migration of MCF7 cell lines was measured using Transwell inserts (8 μm pores, 
Trevigen, MD). Cells suspended in serum-free and phenol free DMEM and applied to the 
upper chamber. Serum and phenol free media with or without IGF-1 added to the lower 
chamber and the plate incubated at 37oC for 24hrs. Non-migrated cells in the upper well 
were removed and the membranes were fixed and stained using 0.01% crystal violet. The 
membranes were either photographed or counted under a light microscope (×100) or the 
dye extracted and the absorbance reading obtained using a spectrophotometer. 
For the Matrigel invasion assay, transwell inserts coated with 0.5 mg/ml Matrigel (BD 
Biosciences, MA) were used. Cells (105 per well) suspended in serum-free and phenol 
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free DMEM were seeded onto the upper chambers of the precoated transwells. Serum and 
phenol free media with or without IGF-1 added to the lower chamber and the plate 
incubated at 37oC for 24hrs. Subsequently, the membranes were fixed, stained, and 
photographed as above or absorbance readings acquired. 
2.3.5 Cell Proliferation Assay 
The MCF7 cell lines expressing Rab5 WT, the inactive form of Rab5 (Rab5:S34N), 
the active form Rab5 (Rab5:Q79L), RIN1 and its isoforms, RIN2 and RIN3, and 
RIN1:R94A mutant or  vector clone were seeded in 96-well plates at a density of 
25 × 103cells/well in 100 ml medium and incubated overnight. Cells were then serum 
starved for 24hrs followed by treatment serum and phenol red free DMEM with or 
without IGF-1 for 48 hrs. After, the MTT solution (5 mg/ml) was added to the plates and 
the cells incubated at 37 °C for 4 hrs. The formazan, derived from MTT by living cells, 
was dissolved in 10% SDS (150 ml per well), and the absorbance was measured at 
595 nm. All MTT experiments were performed in triplicate and repeated at least 3 times. 
2.3.6. Anchorage-Independent Growth Assay 
Briefly, 1 × 103 cells of each cell line were suspended in 300μl of Dulbecco’s 
Modified Eagle’s medium containing 10% calf serum and 0.35% SeaPlaque low-melting 
temperature-agarose. These cells were plated over a 300μl layer of solidified Dulbecco’s 
Modified Eagle’s medium containing 10% calf serum and 0.6% agarose, and cells were 
allowed to settle to the interface between these layers at 37 °C. After 20 min, the plates 
were allowed to harden at room temperature for 30 min before returning to 37 °C. 100μl 
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of vehicle control or IGF-1 was added to wells and the plate incubated at 37 °C. The 
plates were fed every 2–3 days. After 12-14 days, colonies were photographed under low 
magnification (x10).  
 
2.3.7 RNAi constructs and transfection  
The RNAi directed against: mouse RIN1 [5'-
UUAUACAUUUGCUUCACACCUAAGC-3'], was designed and synthesized by 
Ambion (Austin, TX). A scrambled RNAi was designed as a control [5'-
CACCUAAUCCGUGGUUCAA-3']. Prior to RNAi transfection, MCF7 cells were plated 
in growth medium without antibiotics at 30-50% confluency. RNAi (20 nM final 
concentration) transfection was performed using Lipofectamine-2000 (Invitrogen, 
Carlsbad, CA), as specified by Invitrogen. After transfection, cells were used either for 
cell invasion and migration assays. 
2.3.8 Statistical Analysis 
All samples in this study were analyzed in duplicate and each experiment was repeated 
three times. Values represent the mean ± SEM of three independent experiments. To 
compare two groups, student’s t test was utilized. A p < 0.05 was considered as 
statistically significant. 
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2.4 Results 
2.4.1 IGF-1 stimulation triggers the endocytic pathway by upregulating Rab5 activity. 
It is known that Rab5 is a key molecule in insulin and growth factor endoyctosis and 
signaling 3,5,16,22. Furthermore, IGF-1 stimulation mediated the loss of surface IGF-1R 
and formation of Rab11 endosomes in glial cells 42 indicating the role of the endocytic 
pathway in IGF-1 signaling. Given that Rab5 is required for early endocytic activity, the 
possible role of Rab5 in IGF-1 signaling was investigated in breast cancer cells, by 
preparing a stable cell line using a retroviral system in MCF7 cells. As described in the 
Materials and Methods, the cells were infected with a retrovirus encoding GFP-Rab5 
constructs. Stable cell lines over-expressing Rab5 were stimulated with a physiological 
concentration of IGF-1.  Rab5 activation upon IGF-1 stimulation was examined by 
precipitating the active or GTP-bound form of Rab5 with GST-EEA1 domain.  After 5 
mins of growth factor stimulation, the amount of GTP-bound form of Rab5 in cells 
expressing Rab5WT was 5 fold compared to control (Figure 3). The data show that IGF-1 
stimulation promotes the interaction between EEA1 and Rab5 of which the latter must be 
in the active-GTP form. EEA1, a downstream effector of Rab5 is required to tether the 
active GTP-Rab5 to the membrane and facilitate the fusion of the early endosome in the 
trafficking of the activated receptor (Figure 3)5,31,46,51.   
2.4.2 Increase in the proliferative and invasive capacity of IGF-1 stimulated tumor 
cells is dependent on Rab5 activity. 
Prior data have shown cell proliferation is dependent on Insulin receptor (IR) 
activation via Rab5 activation in liver cancer cells 16.  Rab GTPases act as regulatory 
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molecular switches where they hydrolyze the active bound form of GTP to the inactive 
bound form thereby acting as molecular switches23 as they cycle between the active GTP 
and inactive GDP bound forms24.  Early endosome formation and receptor internalization 
and trafficking is dependent on Rab5 activation38. Therefore, it was necessary to show 
that non-aggressive breast tumor cells overexpressing Rab5:Q79L would augment cell 
proliferation because of the rapid IGFR endocytosis.  Hence, it is unsurprising a 
significant increase in cell proliferation was observed in GFP and Rab5WT in the 
presence of IGF-1 breast cancer cells compared to vehicle control (Figure 4a). The cells 
expressing the constitutively active mutant form of Rab5, Rab5:Q79L, had approximately 
4.5 fold increase in cell proliferation when compared to GFP alone while the inactive 
form GDP bound form, Rab5:S34N, had the opposite effect and inhibited growth.  
Considering IGF-1 increased the proliferative capacity of the MCF7 breast cancer cells, 
another experiment was designed to examine whether IGF-1 does indeed play a key role 
via Rab5 activity in cell migration and invasion of tumor cells.  
Within the tumor microenvironment, degradation of the extracellular matrix (ECM) 
releases growth factors including IGF, and they incur a bi-directional response to tumor 
cells growth factor secretion24,61. Both the migratory and invasive action of MCF7 cells 
overexpressing Rab5WT (figures 4b and 4c respectively) was augmented in the presence 
of IGF-1.  
In cells overexpressing the constitutive inactive GDP bound form of Rab5, 
Rab5:S34N, was significantly abrogated in both the vehicle control and IGF-1 stimulated 
cells. Interestingly when the GTP bound form of Rab5, Rab5:Q79L, was overexpressed, 
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migration and invasion of the MCF7 cells were greater than the rates of control cells in 
the absence and presence of IGF-1. 
The invasive potential of Rab5WT was pronounced when compared to those in the 
migration assay (4 fold compared to 2.5), considering the cells must transverse a barrier, 
specifically the basement membrane. This can be attributed to the degradation of the 
ECM by secretion of proteolytic enzymes by the cancer cells and the subsequent release 
of pro- migratory and invasive growth factors10 from the matrigel, which in turn stimulate 
the MCF7 cells. 
2.4.3. IGF-1 stimulates Rab5 activation in breast cancer cells overexpressing Rab5 
specific GEFs  
The switch from the inactive GDP to active GTP state of GTPases are enabled by 
small proteins called guanine exchange factors (GEFs)35. The Ras interfering (RIN) 
family of proteins has been recognized as the GEFs for Rab5 and each one (RIN1, RIN2, 
RIN3) interacted preferentially to inactivated Rab544.  RIN1 is known to interact with the 
EGFR22 and IR17. The role of RIN1 in tumor progression is contrary at best, suggesting 
that RIN1 expression in cancer progression can be growth factor and tissue specific2,9,14. 
The MCF7 cells were transformed using a retrovirus system and selected for RIN1, RIN2 
and RIN3. If  RIN proteins were a requirement for the active Rab5 form, the pull-down 
assay was performed to verify active Rab5 presence in cells overexpressing RIN1, RIN2 
and RIN3 in response to IGF-1. Cells were incubated with IGF-1 for 5mins and the 
amount of active Rab5 generated was quantified using SDS-PAGE after precipitating 
with GST-EEA1 protein. IGF-1 led to more Rab5 activation in tumor cells over 
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expressing RIN1 and RIN3 compared to the vehicle control. Though there was some 
Rab-GTP bound form present in RIN2 expressing cells, it was significantly less in cells 
overexpressing RIN1 and RIN3. 
2.4.4. IGF-1 elicits a strong proliferative, invasive and migratory response in tumor 
cells overexpressing Rab5 GEFs  
On the basis of our results above, it was deduced that expression of Rab5 GEFs may 
also induce cell proliferation and migration in breast cancer cells in response to IGF-1. 
This activity is attributed to the GEF activity in switching Rab5 to the GTP bound form 
and promoting proliferation in the breast cancer cells. Using the Boyden chamber as 
described in the Materials and Methods, a 2-fold and 4-fold increase in cell migration 
was observed in RIN1 and RIN3 cell lines respectively (Figure 6a). While RIN2 
engendered an increase in migration in the presence of IGF-1, it was not much of an 
alteration when compared to the control cell line. Both RIN1 and RIN3 also garnered an 
augmentation of cell invasion in both cell lines (Figure 6b), with RIN3 having less 
invasion of cancer cells compared to RIN1 and the GFP control. Like the Rab5:Q79L 
mutant cell line, RIN1 cancer cells behaved more aggressively even when IGF-1 was 
absent. Whether or not this is significant still needs to be ascertained but initially suggests 
that Rab5 aberration may be key in metastatic progression.  
To further establish the function of RIN1 in mediating pro-invasive response to IGF-1 
in breast cancer cells, RNAi suppression of RIN1 expression was performed and the 
invasive response quantified (figure 9c). Temporal silencing of RIN1 gene expression in 
breast cancer cells significantly inhibited invasion of the cancer cells.  
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2.4.5. IGF-1 fostered in vitro tumor formation in cancer cell and is dependent on Rab5 
activation. 
Tumor formation occurs pre- and post-metastasis where the initial tumor may acquire 
anchorage independence and secondary tumor formation or re-colonization may be both 
anchorage dependent or independent12. It is also important to note that as cancer cells 
continue to feed and increase in size, cells on the perimeter are typically the first cells to 
undergo changes and gain aggressive and highly motile tendencies. Most importantly, it 
only takes one cell for a secondary tumor to develop. 
Here, it was necessary to show that IGF-1 influences colony formation in breast tumor 
cells, particularly through Rab5 activity. Cells overexpressing Rab5WT formed larger 
and more colonies compared to the vehicle control (Figure 10a.) In cells with RIN1 
overexpression (Figure 10b), it was surprising to observe that colony formation, while 
greater in number and more pronounced in size in response to growth factor stimulation. 
Colonies were also numerous and larger in the absence of IGF-1 when compared to the 
control and even RIN3.  
2.5 Discussion 
Cancer cells become highly motile and invasive in response to small alterations in the 
tumor microenvironment and hijack important cellular functions such as cell migration12. 
In light of this behavior, endosomal trafficking in cancer, particularly in the propagation 
of metastasis, is a major point of interest in cancer research. There is increasing evidence 
that the early endocytic molecule, Rab5 GTPase, is a foremost player in cell 
motility/migration of normal and cancer cells as reviewed by Stupack et al.58, and also 
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engaged in lamellipodia formation and actin remodeling in response to growth factor 
stimulation 37,48.  
While Rab5 is expressed differentially in cancer cells, when overexpressed, it was 
identified as a potential modulator of tumor cell transformation to aggressive phenotypes, 
also indicative of its possible role in metastasis 63,66. Additionally, Rab5 GTPases has 
been characterized as an essential signaling molecule in response to growth factor 
stimulation 3,5,16,22.  
Here, it was demonstrated Rab5 had a critical role in the early phases of metastasis, 
specifically affecting the migratory and invasive capacity of breast cancer cells. Yet it is 
not fully determined that IGF-1 signaling is dependent on endocytic trafficking and may 
spur the activation and recruitment of the active form of Rab5 from the cytosol to the 
membrane. 
Circulating IGF-1 levels are higher in breast cancer patients compared with normal 
controls40  while high IGF levels are associated with increased risk of breast cancer in 
pre-menopausal women 13. IGF-1 ensures the survival and hyper-proliferative state of 
cancerous cells. IGF-1 modulates cell proliferation by affecting changes in the apoptotic 
signaling pathways. IGF-1R is found in all breast cancer cell lines regardless of estrogen 
receptor status 8.   
Notably, IGF-1 is known to stimulate the estrogen receptor (ER) in the absence of 
estrogen itself, thereby allowing for more crosstalk between the IGF-1R and ER, 
phosphorylation of the ER and increased synthesis of IGF-1R and ER transcripts19,29,52. 
IGF-1R activation mediate and conformational change in Bad, a pro-apoptotic protein, 
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which inhibited its interaction with the Bcl (anti-apoptotic) proteins and the subsequent 
activation of the caspase chain thereby allowing transformed and pre-cancerous cells to 
escape apoptosis and survive11,28,30.  
Curiously, Rab5 has been shown to be a key regulator in caspase mediated signal 
transduction and facilitates increased motility and survival of cancer cells56,57. This 
suggests that in general, RTK internalization via Rab5, may also result in the increase of 
caspase expression and sequestration of integrins to early endocytic compartments 
suppressing apoptosis of cancer cells.  
In the present study, the proliferative effect of IGF-1 on breast tumor cells was clearly 
evident in the presence of the growth factor and positively correlated to Rab5 expression 
(Figure 5a.). This may be attributed to modulation of apoptotic factors such as caspase-8 
26,53,55  or down-stream activation of adaptor protein, phosphotyrosine interaction, PH 
domain and leucine zipper containing 1(APPL-1) of which the latter has implications in 
growth factor dependent Rab5 activation in ovarian cancer 66. Studies have intimated that 
IGF-1 exerts a strong mitogenic and anti-apoptotic effect on cells and bolsters the pro-
metastatic property of cancer cells by reorganizing integrin receptors and modulating the 
E-cadherin/ B-catenin complex which in turn increases the migratory potential of the 
cells 54,59. 
These intracellular changes of the E-cadherin/ B-catenin complex increase MMPs 
expression, disintegration of the ECM and release of growth factors and push tumor cells 
to a mesenchymal phenotype59.  Rab5 function in the migration and invasion of cells due 
to IGF-1 induction of metastasis suggests that Rab5 mediates the internalization of the 
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activated IGF-1R, either through a clathrin dependent or independent mechanism.  
Specifically, cell migration was dependent on active Rab5 translocation to the plasma 
membrane and formation of early vesicles as the inactive GDP bound form, Rab5:S34N, 
suppressed the migratory aptitude of cancer cells.  A similar pattern was established when 
the invasive capacity of cancer cells was also investigated in response to IGF-1 
stimulation. It was also noted that there was a strong migratory and invasive capacity of 
tumor cells in the cells overexpressing the active Rab5, Rab5:Q79L, irrespective to IGF-1 
stimulation. During metastasis, invading cancer cells acquire an autonomous trait where 
they are less reliant on external growth factors and move in response to internal signaling 
events and secretions. As acknowledged earlier, IGF-1 regulates the pro-survival 
transduction pathway60, and it has been demonstrated that internal forces unleashed in 
cancer cells may also be due to caspases, in a non-apoptotic role. This can potentiate 
migration and invasion in tumor cells and is reliant on Rab5 activation 58. 
 Rab5 activity status seems to be critical in facilitating IGF-1 induced breast cancer 
cell migration and invasion, yet some studies imply that Rab5 may instead be a tumor 
suppressor. In part, this may be attributed to overexpression of a few of the GEFs for 
Rab5, the RIN family of proteins. Specifically it has been suggested that RIN1 may be a 
breast cancer tumor suppressor gene14,34. However, this study suggests otherwise, that 
over-expression of RIN1 and RIN3 fostered an increase in migration and invasion of the 
cancer, with RIN1 eliciting a slightly larger rise in the metastatic potential of the cells 
compared to RIN3. This also implies that RIN1 expression instead, may be a key 
prognostic marker of cancer metastasis and progression9,45.  
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RIN1 is recognized as a regulator of Rab5 as it possesses three features needed in 
early endocytic signaling; Src Homology 2 (SH2), Rab5-GEF and the Ras binding 
domains 18. Though not shown, RIN1 interaction with the IGF-1R via the –SH2 domain 
is a possible precursor for the activation of ERK and PI3K/Akt signaling pathways.  
Due to the highly homologous relationship between IGF-1 and insulin and their 
receptors, it is therefore likely that RIN1 would also regulate IGF-1R internalization and 
promote migration and invasion of breast cancer cells20.  Furthermore, IGF-1 can also 
trans-activate other growth factor receptors like the EGFR and of which the latter has 
been described in studies characterizing the EGFR relationship with RIN1 2,25,43.  
Hence, it can be deduced that this is another mechanism that IGF-1 influences cell 
migration, proliferation and invasion of cancer cells.  In Figure 9c, RIN1 as a principal 
switch in cancer cell metastasis was substantiated when depleted RIN1 levels negated the 
tumor cell invasion alluding to two possible roles of RIN1 in growth actor signaling in 
metastasis: 
1. Action on Rab5 leading to its active form;  
2. Thus, there is direct Rab5 activation and interaction with the cystolic tail of the IGF-
1R ensuring the internalization of receptor and subsequent activation of the 
intracellular signaling pathways.  
Jozic et al. showed that RIN1 facilitated the fusion of the insulin receptor to the early 
endosome and was Rab5 dependent21. Other Rab5 effectors such as Rabaptin are known 
to interact with the platelet-derived growth factor beta receptor (PDGFbetaR) and led to 
deleterious myleoproliferative phenotype in mice32. Rabaptin also functions 
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synergistically with another adaptor for Rabex5 GEF to activate Rab5 and promotes 
early endosomal fusion 65 and receptor internalization41. Whether these Rab5 effectors 
are also involved in IGFR trafficking in tumor progression has yet to be investigated.  
In summary, this study clearly shows that Rab5 and well as its GEFs, RIN1 and 
RIN3, are central players in metastasis of cancer cells especially in the trafficking of the 
activated IGFR. How Rab5 and RIN1 specifically regulates invasion in response to IGF-
1 must still be investigated.  Mendoza et al. suggested that Rab5 modulated focal 
adhesion kinase activity and matrix metalloproteinases (MMPs)  in cancer cells 33, yet 
little information is available as to IGF-1 role in  facilitating  this intracellular response. 
Here, it is shown that the change to an aggressive and invasive phenotype of non-
invasive tumor occurred through Rab5 and RIN1 recruitment and activation in 
trafficking of the IGF-1R upon IGF-1R stimulation.   
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Figure 4. (a) IGF-1 enhances cell proliferation via Rab 5 activation. Cells expressing 
either GFP or GFP-Rab5:WT and its mutants were incubated in the absence or in the 
presence of IGF-1 in triplicate. Cell proliferation was assessed after 48hrs incubation 
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with vehicle or IGF-1 of cell culture, using the MTT proliferation assay (Sigma). Briefly 
after the incubation period, cells were added with 100 μL of 5 mg/mL thiazolyl blue 
tetrazolium bromide (Sigma, St. Louis, MO) solution/well and were incubated further for 
4hrs in a humidified atmosphere (37°C in 5% CO2).  The absorbance was measured at 
560 nm in a microplate reader. Cell proliferation was expressed as the mean percentage 
absorbance compared to vehicle control ± percentage SD for three independent 
experiments. In Figures 4(b) and 4(c), IGF-1 mediates cell invasion and migration in 
MCF7 cells via Rab5 activation. Cells were plated in a boyden chamber with or without 
basement extract membrane. Treatment groups were IGF-1 or vehicle control and cells 
were incubated at 37oC for 16h. Crystal violet staining was performed and the dye 
extracted and the OD measuring using a plate reader at 595nm. Cell migration and 
invasion absorbance reading were expressed as relative OD to control ± SEM for three 
independent experiments where (*) denotes p<0.05, (**) is p<0.01 and (***) is p<0.005. 
 
Figure 5   
 
Figure 5. IGF-1 stimulates Rab5 activation in breast cancer cells overexpressing 
Rab5 specific GEFs MCF7 cells expressing the GEFs RIN1, RIN2, and RIN3 were 
stimulated with IGF-1 or vehicle control for 5 mins and assayed for active GTP-Rab5 as 
described in Materials and Methods. Data represent the mean ± SEM of three 
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independent experiments. (*) represents statistically significant difference from control 
group (P<0.05); n.s. = no significance 
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Figure 6. The Rab5 GEFs mediate cell invasion and migration in MCF7 cells via 
Rab5 activation. As previously outline in Figure 4, tumor cells expressing GFP and the 
Rab GEFs; RIN1 and RIN3. Cells were placed in a Boyden chamber with or without 
basement extract membrane (figures 6a and 6b respectively) Treatment groups were IGF-
1 or vehicle control and cells were incubated ta 37oC for 16h. Crystal violet staining was 
performed and the dye extracted and the OD measuring using a plate reader at 595nm. 
Cell migration and invasion absorbance reading were expressed as relative OD to control 
± SEM for three independent experiments. (*) represents statistically significant 
difference from control group (P<0.05) 
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Figure 7. Rab5 and its GEFs promote colony formation in IGF1 stimulated breast 
cancer cells. Each cell line was plated over a 300ul layer of solidified Dulbecco’s 
Modified Eagle’s medium containing 10% calf serum and 0.6% agarose, and cells were 
allowed to settle to the interface between these layers at 37 °C. 100ul of vehicle control or 
IGF-1 was added to wells and the plate incubated at 37 °C. The plates were fed every 2–3 
days. After 12-14 days, colonies were photographed under low magnification (x10). Each 
cell line was done in triplicate with data represent the mean ± SEM of the three 
independent wells. (*) represents statistically significant difference from control group 
(P<0.05); (**) is (P<0.01) and (***) is (P<0.001) 
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CHAPTER 3.  
 
Requirements of Rab5 Activity in Highly Invasive Breast Cancer Cell Lines. 
 
This chapter sought to elucidate the functional role of Rab5 in facilitating cell migration 
and invasion in invasive breast cancer cells.  
3.1 Abstract 
Rab5 expression in cancer has been associated with diseases progression and prognosis. 
Growth factor-directed cell invasion and migration was dependent on Rab5 activation in 
non- invasive breast cancer cells. However, hardly any data are available regarding the 
role of Rab5 in invasive cells in the absence and presence of growth factors. 
In this study, it is reported that the invasive and migratory properties of the triple 
negative highly invasive breast cancer cell line, MDA-MB-231, were abrogated in cells 
expressing the inactive (GDP-bound) form of Rab5 irrespective of growth factor 
stimulation, while the invasive potential of breast cancer cell lines expressing the 
Rab5:WT and the active form of Rab5 mutant (Rab5:Q79L) were noticeably greater. 
Rab:S34N significantly suppressed the migratory and invasive capacity of MDA-MB-231 
cells. Interestingly, expression of RIN1, a Rab5 GEF, increases invasion and migration of 
MDA-MB-231 cells even in the absence of growth factors. In contrast, RIN1:R94A 
mutant partially mitigates both processes. Hence, it is reasonable to speculate that cell 
invasion and migration, a process that typically involves activation of IGF-1 receptor, can 
be intracellularly regulated without intervention or activation of growth factor receptors, 
but elicits a greater invasive response if growth factors are present. 
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3.2. Introduction 
Over the last few years, Rab proteins have been specifically linked to the deregulation 
of several signaling pathways in a variety of cancers and also been implicated in the 
promotion of abnormal migratory and invasion of epithelial cells in tumor progression 
5,6,25. Rab5, a member of this prolific Rab GTPase family, has generated a lot of interest 
in cancer development and progression given the myriad of cellular functions that the 
protein regulates. Rab5 is involved in vesicle formation, early endosome docking and 
fusion, translocation from plasma membrane to various organelles within the cell through 
the recruitment of small factors that include phosphatases, kinases, adaptor proteins as 
well as actin filaments and microtubules in cell migration and mitosis 29.  
Endocytosis is an indispensable signaling mechanism in growth factor induced 
signaling, it is worth considering the early factors such as Rab5 that exert a great 
influence on intracellular trafficking and also as a coordinator in the crosstalk amongst 
signaling pathways in cancer pathogenesis. Within cancer biology, recent studies have 
pinpointed Rab proteins as a possible controller of the metastatic expression of cancer 
cells with influence on the degree of malignancy in lung and stomach cancer. 
Based on the data derive from the first Aim, it was demonstrated that Rab5 activity 
drives the metastatic potential in non-invasive tumorigenic breast cancer cells. Whilst 
Rabs are currently not considered to be oncogenic, there is growing evidence that may 
suggest otherwise17,22,28,36,38,39. 
Insulin Growth Factor 1 (IGF-1) is pathologically critical in cancer development and 
progression. Epidemiological studies has implicated free IGF-1 serum levels as a risk 
factor for the development and progression of breast, prostate, colon, and lung cancer 
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11,23. Davison et al. has shown that triple negative highly invasive breast cancer cells were 
highly sensitive to IGF-1 which promoted cell proliferation and survival 7. While there is 
a plethora of data regarding the IGF-1 and its receptor in cancer metastasis, there is a 
paucity of research specifically regarding the relationship between Rab GTPases and 
IGF-1R in cancer progression. 
Interest has been building regarding the dynamic interplay between endocytosis of 
receptor tyrosine kinases (RTK) and signaling. During endocytosis, receptors are active 
within the endosomes16 thereby supporting the theory that membrane trafficking is a 
regulator in growth factor signal transduction. Metastatic factors such as hepatocyte 
growth factor (HGF), epithelial growth factor (EGF), transforming growth factor β (TGF 
β) and insulin growth factor 1 (IGF-1) are known to activate the endosomal pathway and 
the mechanisms can be analogous at key junctions thereby promoting a migratory 
response in tumor cells. 
The role of clathrin-mediated endocytosis in EGF-directed chemotactic invasion of 
breast cancer20 and internalization and co-localization of the IGF-1R with clathrin and 
caveolin-1 in Ewing sarcoma cells18 denoted the relationship of endocytosis and RTK 
trafficking in cancer. Other studies have established that IGF-1R is also localized in the 
nucleus in prostate, renal and breast tumor cells after translocation from the cell 
surface1,and Rab5a is characterized as a significant molecule in ovarian cancer upon EGF 
stimulation40. 
On the other hand, Rab5c has been implicated in EGFR signaling by affecting integrin 
recycling and triggering cell invasion in some breast cancer cells22. Hepatocyte growth 
factor receptor (Met) trafficking requires Rab5 and facilitates focal adhesion turnover, 
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actin remodeling and sustained MAPK signaling thereby underscoring its role in 
tumorigenesis, cell migration and invasion12.  
Rab5-dependent IGF-1-signaling may a noteworthy aspect of cancer metastasis based 
on earlier results. Given that the potential role IGF-1R trafficking in invasive breast 
cancer is unknown, this study sought to explore and highlight the possible role of early 
endosomal trafficking in mediating phenotypic changes in the promotion of proliferation, 
migration and invasion activities of invasive breast cancer cells in the presence of IGF-1. 
3.3. Materials and Methods 
3.3.1. Media and Antibodies.  
Trypsin and DMEM medium were purchased from Fisher Scienific. Basement extract 
membrane was obtained from Trevigen (Gaithersburg, CA). The following antibodies 
were used for Western blotting: Rab5, FAK, MMP-2, MMP-9, anti-ERK, cJun, p38, Akt, 
phospho-ERK, phospho-cJun, phospho-p38, phospho-Akt, GAPDH , (Cell Signaling 
Technology, Danvers,MA).  Anti-mouse, and anti-rabbit IgG peroxidase-conjugated 
secondary antibodies were purchased from Jackson ImmunoResearch Laboratories (West 
Grove, PA).  
3.3.2. Cell Culture. 
The human breast cancer cell line, MDA-MB-231, was obtained from the American 
Type Culture Collection (ATCC; Manassas, VA, USA). Cells were maintained in DMEM 
medium supplemented with 10% fetal calf serum, 2 mM glutamine, and antibiotics (100 
U/mL penicillin and 100 lg/mL streptomycin) at 37oC in a humidified atmosphere of 5% 
CO2. 
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3.3.3. Construction of Recombinant pMX-puro retroviruses and cell lines 
As previously described, the cDNAs of Rab5 and Rin1 and their mutants were 
subcloned into the pMX-puro vector 2. Transfection of 60% confluent  PhoA cells was 
performed using Fugene (Roche) and the virus harvested after 48 hours post-transfection. 
MDA-MB-231 cell line was infected with the retrovirus tagged with green fluorescent 
protein (GFP) and Rab5, Rin1 and control cell lines were generated and selected after 72 
hours.  
3.3.4. Rab5-GTP activation pull down assay 
MDA-MB-231 cell lines were lysed using a buffer containing 20 mM HEPES (pH 
7.5), 100 mM NaCl, 1 mM DTT, 5 mM MgCl2, 5% (v/v) glycerol and 1% (v/v) Triton-X-
100 supplemented with 1 mM PMSF. Lysates (1.5ug) were then incubated with 1μl anti-
active Rab5 monoclonal antibody (Neweast Biosciences, Mavern, PA) overnight at 4°C. 
The following day, cells were incubated with a protein A/G agarose bead slurry for 1 hr. 
After incubation, the beads were washed three times using the lysis buffer and 
resuspended in loading sample buffer. The pull-downs were subjected to SDS-PAGE and 
analyzed by immunoblotting using an anti-Rab5 antibody. 
3.3.5. Cell Proliferation Assay 
The viability of cells was determined by the MTT assay. MDA-MB-231 cell lines 
expressing Rab5 WT, the inactive form S34N,  active form Q79L, Rin1, Rin2, Rin3, Rin1 
mutant (R94A) or null vector were seeded in 96-well plates at a density of 
25 × 103cells/well and incubated overnight. Cells were then serum starved for 24 hours 
followed by treatment with serum and phenol red free DMEM with or without charcoal 
stripped 5% FCS for 48 h. The MTT solution (5 mg/ml) was added to the plates and the 
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cells incubated at 37 °C for 4 h. The formazan, derived from MTT by living cells, was 
dissolved in 10% SDS (150 ml per well), and the absorbance was measured at 595 nm on 
a plate reader. All MTT experiments were performed in triplicate and repeated at least 3 
times. 
3.3.6. Cell Migration/ Invasion assay 
The ability of MDA-MB-231 cells passing through Matrigel coated or uncoated filters 
was measured by the Boyden chamber invasion assay using Transwell inserts (8 μm 
pores, Trevigen, MD). Cells suspended in serum-free and phenol free DMEM and 
applied to the upper chamber. Serum and phenol free media with or without FCS as the 
chemotractant added to the lower chamber and the plate incubated at 37oC for 24hrs. 
Non-migrated cells in the upper well were removed and the membranes were fixed and 
stained using 0.01% crystal violet. The membranes were either photographed or counted 
under a light microscope (×100) or the dye extracted and the absorbance reading obtained 
using a spectrophotometer. 
For the Matrigel invasion assay, transwell inserts coated with 0.5 mg/ml Matrigel (BD 
Biosciences, MA) were used. Cells (105 per well) suspended in serum-free and phenol 
free DMEM were seeded onto the upper chambers of the precoated transwells. Serum and 
phenol free media with or without charcoal stripped FCS was added to the lower chamber 
and the plate incubated at 37oC for 24hrs. Susequently, the membranes were fixed, 
stained, and photographed as above or absorbance readings acquired. 
3.3.7. Wound-healing Assay 
Cells were placed in inserts with a gap 500nm (+ 50nm) (Ibidi, Verona, WI) and 
incubated at 37oC. After serum starvation for 24hrs, the inserts were removed, the wells 
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were washed with PBS and medium with or without 5% charcoal stripped FBS was 
added. Cell migration was determined under the inverted microscope and pictures were 
obtained at time = 0 and t= 16hrs. 
3.3.8. Anchorage-Independent Growth Assay 
Briefly, 1 × 103 cells of each cell line were suspended in 300ul of DMEM containing 
10% calf serum and 0.35% SeaPlaque low-melting temperature-agarose. These cells were 
plated over a 300ul layer of solidified DMEM containing 10% calf serum and 0.6% 
agarose, and cells were allowed to settle to the interface between these layers at 37 °C. 
After 20 min, the plates were allowed to harden at room temperature for 30 min before 
returning to 37 °C. 100ul of vehicle control or IGF-1 was added to wells and the plate 
incubated at 37 °C. The plates were fed every 2–3 days. After 12-14 days, colonies were 
photographed under low magnification (x10).  
3.3.9. Western Blot Analysis 
MDA-MB-231 cells were lysed with RIPA buffer containing protease inhibitor. Equal 
amounts of protein (50 ug) were separated by SDS–PAGE gel electrophoresis and then 
were electrotransferred to nitrocellulose membrane. Subsequent to blocking the 
membrane with a solution containing 5% BSA- TBST buffer (20 mM Tris–HCl, pH 7.4, 
150 mM qNaCl and 0.1% Tween 20) for 1hr, the membrane e was washed with TBST 
buffer and incubated with the primary antibodies. Membranes were then washed; probed 
with specific secondary antibodies and the proteins were detected by enhanced 
chemiluminescence. 
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3.3.10. Statistical Analysis 
All samples in this study were analyzed in duplicate and each experiment was repeated 
three times. Values represent the mean ± SEM of three independent experiments. To 
compare two groups, student’s t test was utilized. P < 0.05 was considered as statistically 
significant. 
3.4. Results 
3.4.1. IGF-1 endocytosis is mediated by Rab5 protein expression in breast cancer cells 
To study the effects of Rab5, GFP-Rab5 constructs were transduced into the MDA-
MB-231 tumor cell line with a retrovirus system. Stable cell lines over-expressing Rab5 
were stimulated with a physiological concentration of IGF-1.  Rab5 activation upon IGF-
1 stimulation was examined by precipitating the active or GTP-bound form of Rab5 
antibody (see Materials and Methods).  After 5 minutes of growth factor stimulation, the 
data shows that IGF-1 stimulation elicits a significant increase (a little over 3-fold) of 
active Rab5 (Figure 8), suggesting that IGF-1 signaling may be Rab5 dependent in MDA-
MB-231 cells. 
3.4.2. IGF-1 stimulated Rab5 activation in breast cancer cell overexpressing Rab5 
specific GEFs 
MDA-MB-231 cells were transformed using the aforementioned retrovirus system and 
selected for overexpression of RIN1, RIN2 and RIN3. As it was previously described, 
Rab5 activation can be described as molecular switch where GTPases cycle from an 
inactive to an active form. This switch is mediated by Rab5- specific GEFs and may also 
regulate RTK membrane trafficking.  
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To evaluate if cells expressing RIN1, RIN2 and RIN3 may be a requirement for Rab5 
activation in IGF-1R trafficking, the pull-down assay was performed to verify active 
Rab5 presence in cells overexpressing RIN1, RIN2 and RIN3 in response to IGF-1. Cells 
were incubated with IGF-1 for 5mins and the amount of active Rab5 generated was 
quantified using SDS-PAGE after precipitating with active Rab5 monoclonal antibody.  
3.4.3. Rab5 promotes cell migration and invasion in breast cancer cells 
Cell migration and invasion were measured with the aid of a transwell system. Briefly, 
cells expressing the different Rab5 constructs were placed in the Boyden chamber in 
absence or presence of matrigel and incubated overnight.  In Figures 10a and 10c, there 
was a marked increase in the migratory and invasive potential of cancer cells over 
expressing Rab5. As expected, cells expressing the constitutively inactive form of Rab5, 
Rab5:S34N, inhibited migration and invasion of the cancer cells compared to the control 
cells. While IGF-1 seems to have a profound impact on the migratory potential in the 
S34N cell line when compared to cell invasion, it was still less that both the Rab5WT and 
Rab5:Q79L active mutant. 
These data also reveal that even in the absence of IGF-1, it seems that Rab5 activity 
encourages more migration and invasion in both WT and Q79L cell lines when compared 
to the GFP control. The migration abilities of the MDA-MB-231 breast cancer cell lines 
were also verified using the wound healing method after 18 hrs. Cells transduced with the 
Rab5-GDP bound form had a little migration, as the gap closure was similar to the 0hr 
timepoint and wider than GFP control. Both Rab5:WT and Rab5:Q79L cell lines 
demonstrated extensive gap closing which suggest that Rab5 activation may be key in 
modulating such activity. 
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3.4.4. The Ras-interfering family (RIN) increases cell proliferation, migration and 
invasion upon IGF-1 stimulation 
Given the results above, it was speculated that expression of Rab5 GEFs may also 
induce cell proliferation, migration and invasion in breast cancer cells in response to IGF-
1.  In MDA-MB-231, IGF-1 has been purported to exert a strong proliferative effect 7 and 
it was necessary to verify if RIN expression may modulate this response in the breast 
cancer cells. Cells expressing RIN1, RIN2 and RIN3 were plated, incubated for 48hrs in 
the absence or presence of IGF-1 and the proliferative activity measured using the MTT 
assay as described in the Materials and Methods. Figure 11 depicts the promotion of cell 
proliferative by the RIN family of GEFs in response to IGF-1. To further validate the 
function of RIN1 in IGF-1 signaling in cancer progression, cell migration and invasion 
assays using the Boyden chamber as described in the Materials and Methods bolstered 
previous data that the invasive and migratory activity of cells were augmented in 
response to RIN1, RIN2 and RIn3 expression. 
Figures 12a and 12b portrayed a strong increase in cell invasion and migration in 
RIN1 and RIN3 cell lines, even in the absence of IGF-1, suggesting that RIN activity be a 
driving force regardless of growth factor presence. RIN2 engendered an increase in 
migration in the presence of IGF-1, while invasion was not noticeable when compared to 
the control cell line.  
 
 
 
89 
3.4.5. Functional role RIN1 on the invasive and migratory potential in MDA-MB231 
Cells 
As described in Figures 13a and 13b, RIN1 appears to be a principal regulator in 
cancer cell metastasis. In Aim one, two scenarios arose with regard to RIN1 role in 
growth factor signaling:  
1. Action on Rab5 leading to its active form; 
 2. Interaction with the cystolic tail of the IGF-1R ensuring the internalization of 
receptors and subsequent activation of the intracellular signaling pathways.  
To further elucidate RIN1 function in growth factor signaling, stable cell lines 
expressing RIN1 and the RIN1 mutant, R94A were created and the proliferative, 
migratory and invasive capacities were studied.  Jozic et al. showed that RIN1 facilitated 
the fusion of the insulin receptor to the early endosome and was Rab5 dependent15 via 
RIN1 activity. This study further supports the idea that RIN1 interacts with the IGF-1R 
via the –SH binding domain as the R94A mutant significantly diminished proliferation, 
migration and invasion in breast cancer cells. Interestingly during invasion, RIN1 seems 
to have a greater interaction in response to IGF-1R as the absorbance was greater in 
response to IGF-1 supplementation. 
3.5. Discussion 
Rab5 is an important factor in the regulation of intracellular vesicle transport and 
recently garnered interest in its role in the pathogenesis of certain diseases, specifically 
cancer. Earlier, it was shown that Rab5 may be an important protein in the onset of breast 
cancer metastasis as non -aggressive tumorigenic breast cancer cells acquired a highly 
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invasive and migratory phenotype when Rab5 was overexpressed. Furthermore, IGF-1, a 
potent mitogen seems to facilitate such changes as growth factors are integral in tumor 
progression 4,9. 
Studies have shown that Rab5 is expressed differentially in different cancer 
subtypes38,40. Expression of Rab5 in non-invasive and invasive breast cancer cell lines 
varies; where Rab5 distribution throughout the cells in different breast tumor grades were 
disparately localized36. 
As previously reported, an inherent relationship exists between RTK activation and 
internalization 2,3,25 and has been attributed to Rab5 activation.  Figures 11 and 12 
showed that IGF-1 activated the IGF-1R resulting in sequestration of active Rab5 to early 
endosome and consequently the possible stimulation of the PI3K and MAPK pathways 
which are necessary in initiating cell migration and invasion. While this study is the first 
to show IGF-1 influence on the endocytic pathway on the migratory and invasive 
capacity of MDA-MB-231 cells, Yang et al provided possible answers that most if not all 
growth factors and their RTKs will have analogous behavior36. 
In MCF7 cells, EGF did not promote cell migration despite the associated increase of 
Rab5A expression. However, in MDA-MB-231 cells, the growth factor augmented the 
migratory potential in relation to Rab5 expression and may be due to the RTK levels in 
these cells. IGF-1R is found in all breast cancer cell lines regardless of estrogen receptor 
status7 and is predominant in both estrogen responsive MCF7 and estrogen unresponsive 
MDA-MB-231 cells. Although it is known that IGF-1 can stimulate the ER in the 
absence of estrogen, this study supplements data from the first aim that the IGF-1R 
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activation is necessary for migration and invasion of breast cancer cells and more than 
likely does not involve crosstalk between the ER. 
In this study, the role of Rab5 in facilitating IGF-1 induced breast cancer metastasis is 
further clarified as overexpression of the Rab5WT and the active mutant form of Rab5 
increased migration and proliferation. Conversely when inactive form of Rab5:S34N 
mutant, was expressed, proliferation and migration was stemmed. Taken together, it can 
deduced that the function of Rab5 is tightly linked to IGF-1 and IGF-1R signaling in 
breast cancer metastasis. 
During migration and invasion of cancer cells, reorganization and reconstruction of 
the actin filament and microtubules are part of the morphological changes that these cells 
undergo26,37. Cancer cells employ four key steps that facilitate this process: lamellipodia 
formation and extension at the forefront, translocation of integrins to the leading edge, 
contractile movement of the cell body and detachment of adhesion molecules at the rear 
edge24. Actin remodeling and cell migration is dependent on Rho GTPase and Rac 
activity of which these proteins are trafficked by Rab13 and Rab5 respectively and affect 
the internalization of integrins during cell migration32,35,39. 
Rab5 depletion in HeLa and SiHa cells affected integrin trafficking, compromised 
filopodia and lamellipodia protrusion formation and reduced the cells’ capacity to 
migrate and invade17, whereas in ovarian cancer, Rab5a overexpression elevated the 
proliferative activity of ovarian cancer cells40. Migration of cells in hepatocellular 
carcinoma was dependent on VEGF/PDGF (platelet derived growth factor) and EGFR 
mediated tyrosine kinase endocytosis via Rab5 10, hepatitis B induced Rab5 expression28. 
Consequently, the data and studies involving growth factor/ RTK trafficking and Rab5 
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function collectively establish Rab5 as a regulator in IGF-1 mediated metastasis in breast 
cancer cells. 
Though Rab5 activation may be a requirement in cancer cell proliferation, migration, 
invasion and survival, other factors may influence Rab5 activity and lead to the 
internalization of the phosphorylated receptor. The RIN family of proteins are regulators 
of Rab5 dependent early endocytosis via their GEF activity. They are homologous as they 
share an SH2 domain, an RH region, a Vps9 domain and an RA domain. Though 
controversial, RIN1 appear to exert its influence on Ras by inhibiting its action whilst 
binding to H-Ras via the RA domain thereby competing with RAF133,34.  In Aim1, it was 
shown that both RIN1, RIN2 and RIN3 enabled MCF7 cells to garner a more hyper-
proliferative and invasive characteristic and this is reflected in the triple negative highly 
invasive MDA-MB-231 cells. The conflicting role of RIN1 function can only be resolved 
by viewing RIN1 activity in RTK trafficking in a context-specific manner. On one hand, 
RIN1 may be a breast cancer tumor suppressor gene13,19 by suppression of cancer 
tumorigenesis and inhibition of transforming growth factor β (TGFβ) signaling. The 
latter however has contrary roles in tumorigenesis and metastasis as typically in early 
non-metastatic tumor (epithelial to mesenchymal transition), TGFβ levels are too low to 
facilitate such change, yet once cells are malignant, TGFβ promote cancer progression 
and dissemination31. This may be the case for this study, as MDA-MB-231 are already 
quite aggressive and over expression of RIN1 has a paradoxical effect and instead 
augments  proliferation and invasion of the cells in response to IGF-1. Previous studies 
have indeed highlighted RIN1 expression as a major indicator of cancer metastasis and 
progression8,27. 
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IGF-1 has a significant effect on triple negative breast cancer cell lines by fostering 
proliferation and reducing apoptosis and attenuation of such response and when the IGF-
1R expression was curbed7, cell proliferation and survival was abrogated. Modulation 
IGF-1R trafficking affected the proliferative, migratory and invasive potential of breast 
cancer cells. RIN1 beside possessing a Rab5 specific binding domain, also encodes a 
SH2 binding site that may interact with the insulin receptor substrate (IRS) on the 
phosphorylated tyrosine residues of the IGF-1R 21. Here, mutation in the SH2 binding 
domain of RIN1 implied that RIN1 is crucial in IGF-1 signaling as cells expressing the 
RIN1 mutant, R94A, considerably moderated proliferation, migration and invasion of 
MDA-MB-231. Therefore it can be tentatively concluded that RIN1 is first recruited to 
the activated receptor, then engages Rab5 via its Vsp9 binding domain, with Rab5 
subsequent activation. Comparatively, SH2 dependent interaction has been illustrated for 
RIN1 and other RTKs, specifically EGFR resulting in the recruitment and internalization 
of activated RTKs in endosomes14,30. 
Overall, the data presented shows that both Rab5 and RIN1 point to a novel 
relationship between IGF-1R trafficking and endocytosis in the regulation of migration 
and invasion of breast cancer cells. It remains to further elucidate if IGF-1R 
internalization may also be clathrin or caveolin dependent and the effect of IGF-1R 
trafficking on downstream signaling in IGF-1 driven breast cancer cell invasion and 
migration. 
3.6. Figures 
Figure 8 
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(c)                                                                   Invasion               
 
Figure 10. IGF-1 mediates cell invasion and migration in MDA-MB-231 cells via Rab5 
activation. In Figures 10a and b, cells were plated in a Boyden chamber without or 
without basement extract membrane. Both kinase and caveolin inhibitors were added to 
cells for 1hr. Treatment groups were IGF-1 or vehicle control and cells were incubated ta 
37oC for 16hrs. Crystal violet staining was performed and the dye extracted and the OD 
measuring using a plate reader at 595nm. Cell migration and invasion absorbance reading 
were expressed as average ± SEM for three independent experiments. For MDA-MB-231 
cell migration (Fig. 10b), an IBIDI culture insert (IBIDI GmbH) was placed into wells of 
a 24 well plate and slightly pressed on the top to ensure tight adhesion. An equal number 
of cells were placed in each of the insert and the cells incubated for 16hrs. Gap closure 
was observed at a magnification of 10X and images recorded. Crystal violet staining was 
done for better imaging of the migration of the cells. Each cell line was done in triplicate 
with data represent the mean absorbance ± SEM of the three independent wells. (*) 
represents statistically significant difference from control group (P<0.05); (**) is 
(P<0.01). 
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Figure 11.                                          Proliferation 
 
 
Figure 11. The Ras-interfering family (Rin) increases cell proliferation upon IGF-1 
stimulation. Cells expressing either GFP, RIN1, RIN2 and RIN3 were incubated in the 
absence or in the presence of IGF-1 in triplicate. Cell proliferation was assessed after 
48hr incubation with vehicle or IGF-1 of cell culture, using the MTT proliferation assay 
(Sigma). Briefly after the incubation period, cells were added with 100 μL of 5 mg/mL 
thiazolyl blue tetrazolium bromide (Sigma, St. Louis, MO) solution/well and were 
incubated further for 4hrs in a humidified atmosphere (37°C in 5% CO2).  The 
absorbance was measured at 560nm in a microplate reader. Cell proliferation was 
expressed as the mean absorbance compared to vehicle control ± SEM for three 
independent experiments. (*) represents statistically significant difference from control 
group (P<0.05); (**) is (P<0.01); (***) is (P<0.001) 
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Figure 12 
(a)                                                     Invasion 
 
(b)                                          Migration 
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Figure 12. RIN1 and its family facilitate an increase in invasion and migration upon 
IGF-1 stimulation in cancer cells. Cells expressing either GFP, RIN1, RIN2 and RIN3 
were incubated in the presence or absence basement extract membrane in a Boyden 
chamber in triplicate. Treatment groups were IGF-1 or vehicle control and cells were 
incubated ta 37oC for 16hrs. Crystal violet staining was performed and the dye extracted 
and the OD measuring using a plate reader at 595nm. Cell invasion and migration was 
expressed as the mean absorbance compared to vehicle control ± SEM for three 
independent experiments. (*) represents statistically significant difference from control 
group (P<0.05); (**) is (P<0.01); (***) is (P<0.001) 
Figure 13 
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(b)                                                         Migration 
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(c)                                                   Invasion 
 
Figure 13a. IGF-1 enhances cell proliferation through GEF overexpression. Cells 
expressing either GFP , RIN1, and the RIN1 mutant R94A were incubated in the absence 
or in the presence of IGF-1 in triplicate. Cell proliferation was assessed after 48hr 
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incubation with vehicle or IGF-1 of cell culture, using the MTT proliferation assay 
(Sigma, St. Louis, MO). Briefly after the incubation period, cells were added with 100 μL 
of 5 mg/mL thiazolyl blue tetrazolium bromide (Sigma, St. Louis, MO) solution/well and 
were incubated further for 4 h in a humidified atmosphere (37°C in 5% CO2).  The 
absorbance was measured at 595 nm in a microplate reader. Cell proliferation was 
expressed as the mean absorbance compared to vehicle control ± SEM for three 
independent experiments.  (*) denote p value < 0.05 for vehicle control. Effect of Rin1 
on the invasive and migratory potential in MDA-MB231 cells. In Figure b, MDA-
MB231 cells were infected with Rin1, Rin1 mutant R94A and the null vector GFP. Cells 
were placed in a Boyden chamber with or without basement extract membrane (Figures 
b. and c. respectively) Treatment groups were IGF-1 or vehicle control and cells were 
incubated ta 37oC for 16hrs. Crystal violet staining was performed and the dye extracted 
and the OD measuring using a plate reader at 595nm. The average OD ± SEM of the (b.) 
cell invasion and (c.) cell migration readings were obtained for three independent 
experiments. (*) denotes (P< 0.05), (**) is (P<0.01), (***) is (P<0.001). 
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CHAPTER 4. 
 
Caveolin dependent trafficking of IGF-1R is a key step in Cell Migration and 
Invasion of Breast Cancer Cells 
Within this chapter, the functional roles of Rab5 and RIN1 in IGF-1R trafficking were 
further characterized. The effect on the gene expression was of a key protein in cell 
invasion, MMPs was also investigated. 
4.1. Abstract 
IGF-1signaling has been extensively studied in several developmental contexts and 
most recently within cancer pathogenesis. IGF-1 is known to increase cell proliferation 
and survival and may also be implicated in cell migration and cell invasion. However, 
there is a dearth of information regarding IGF-1R trafficking upon IGF-1 stimulation in 
breast cancer progression. It has been described that Rab5 and its GEF, RIN1, play key 
roles in RTK trafficking and influence the invasive and migratory potential of cells. 
In this study, two non-invasive ER positive and highly invasive triple negative breast 
cancer cell lines were transfected with Rab5 and RIN1 constructs and the mechanisms 
surrounding IGF-1R endocytosis was investigated. Blocking of the IGF-1R revealed that 
IGF-1 signaling was contingent on receptor activation and recruited RIN1 and early 
endosome formation via a sẅcaveolae dependent mechanism.  Furthermore, Rab5 and 
RIN1 overexpression increased MMP9 expression establishing a novel link among IGF-
1R activation and signaling and MMP activation in migration and invasion of breast 
cancer cells. 
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4.2. Introduction 
Like most if not all cancers, breast cancers commandeer highly regulated signaling 
pathways and alter these signaling pathways resulting in autonomous growth signal 
entities17,42. They upset the delicate balance by promoting the binding of multiple growth 
factors to cell surface receptors, synthesize growth signals that can either bind to their 
own receptor, forming an autocrine loop or influence the secretion of more growth factors 
by normal cells into the stroma6,13, which then binds again to the receptors on the cancer 
cells, creating a paracrine feedback loop.  
In mammary epithelial cells, malignancy has been attributed to an increase in cell 
proliferation, survival and metastasis, specifically cell migration and invasion. IGF-1 has 
been strongly implicated in breast cancer progression as it facilitates cell proliferation and 
survival in breast cancer cells18. In fact, circulating IGF-1 levels have a strong positive 
correlation with worsening breast cancer prognosis, especially among menopausal 
women18, thereby indicating that breast cancer is not always hormonally dependent as 
previously believed. 
While growth factors may induce transformations in signaling pathways in cancer 
pathogenesis, Rab proteins have also been specifically linked to the deregulation of 
several signaling pathways in several cancers12. These small monomeric enzymes are 
implicated in the promotion of abnormal proliferation, migration and invasion of 
epithelial cells in tumor progression due to activation of membrane bound growth factor 
receptors. Rab5 is one such GTPase that is gaining notoriety in tumor progression and 
metastasis27,40. As it was previously shown in the aforementioned Aims, Rab5 activity 
play a key role in cell migration and invasion in both estrogen positive and negative 
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breast cancer cell lines. Furthermore, it is believed that disruption of the endocytic 
pathway confers growth factor autonomy to cancer cells by passing key endocytic 
processes such as lysosomal degradation and instead promote the recycling of growth 
factors as well as integrins11,15,28. 
IGF-1 binds to a variety of insulin-like growth factor receptors (IGFRs) including the 
insulin receptor (IR). These receptor tyrosine kinases (RTKs), when activated, transduce 
signals through PI3K and MAPK-dependent mechanisms which are responsible for the 
diverse target actions of these growth factors. These include increases in cell division, 
cell size, protein synthesis, cell migration, and inhibition of apoptosis21. IGF-1 can also 
potentiate VEGF expression of tumor cells and inhibit apoptosis by binding to caspase 9, 
which is unable to cleave caspase 3 and halting the caspase cascade to apoptosis36. The 
pro-survival effect of IGF-1 also allows detached pre-metastatic cells to escape anoikis 20 
, facilitate the secretion of more growth factors by cancer cells and induce ECM 
degradation by enabling the matrix metalloproteinases (MMPs) expression and 
secretion39.  IGF-1 also mediate cell migration of cancer cells by reorganizing integrin 
receptors, and modulating the E-cadherin/ β-catenin complex which in turn, augment  
MMPs expression and the migratory potential of the cells41. 
The aforementioned studies (Aims 1 and 2) illustrated that IGF-1 signaling is 
mediated by Rab5 and RIN1 activities. Recently, it was acknowledged that IGF-1R is 
internalized via clathrin and caveolin dependent mechanisms in Ewing sarcoma30 cells 
and is localized in the nucleus in prostate, renal and breast tumor cells after translocation 
from the cell surface via clathrin mediated endocytosis1. Yet, during IGF-1 driven cell 
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invasion and migration of breast cancer cells, it is remains unclear if IGF-1R trafficking 
is caveolin dependent or independent. In this study, IGF-1R trafficking utilized primarily 
caveolin dependent, and inhibition of IGF-1R activation and/ or internalization can alter 
cancer cell progression. Hence, there is a novel link between RIN1, Rab5, MMP9 
expression and IGF-1R signaling in tumorigenesis and metastasis in both non-invasive 
and invasive cancer cells.  
4.3. Materials and Methods 
4.3.1. Media and Antibodies 
Trypsin and DMEM were purchased from Fisher Scientific. Basement extract 
membrane was obtained from Trevigen (Gaithersburg, CA). The following antibodies 
were used for Western blotting: Rab5, MMP-9, anti-ERK, p38, Akt, phospho-ERK, 
phospho-cJun, phospho-p38, phospho-Akt, GAPDH , (Cell Signaling Technology, 
Danvers,MA).  Anti-mouse, and anti-rabbit IgG peroxidase-conjugated secondary 
antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove, 
PA).  Kinase inhibitors were obtained from Sigma (St. Louis, MO). 
4.3.2. Cell Culture 
The human breast cancer cell line, MDA-MB-231, was obtained from the American 
Type Culture Collection (ATCC; Manassas, VA, USA). Cells were maintained in DMEM 
medium supplemented with 10% FCS, 2mM glutamine, and antibiotics (100 U/mL 
penicillin and 100μg/mL streptomycin) at 37oC in a humidified atmosphere of 5% CO2. 
4.3.3. Construction of recombinant pMX-puro retroviruses and cell lines 
As previously described, the cDNAs of Rab5 and Rin1 and their mutants were 
subcloned into the pMX-puro vector 5.Transfection of 60% confluent  PhoA cells was 
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performed using Fugene (Roche) and the virus harvested after 48hrs post-transfection. 
MCF7 and MDA-MB-231 cell lines were infected with the retrovirus tagged with green 
fluorescent protein (GFP) and Rab5, Rin1 and control cell lines were generated and 
selected after 72hrs.  
4.3.4. Cell Proliferation Assay 
The viability of cells was determined by the MTT assay. MCF7 and MDA-MB-231 
cell lines expressing Rab5 WT, Rin1, Rin1 mutant (R94A) or null vector were seeded in 
96-well plates at a density of 25 × 103cells/well and incubated overnight. Cells were then 
serum starved for 24hrs followed by treatment with serum and phenol red free DMEM 
with or without charcoal stripped 5% FCS for 48hrs. The MTT solution (5 mg/ml) was 
added to the plates and the cells incubated at 37 °C for 4hrs. The formazan, derived from 
MTT by living cells, was dissolved in 10% SDS (150μl per well), and the absorbance 
was measured at 595nm on a plate reader. All MTT experiments were performed in 
triplicate and repeated at least 3 times. 
4.3.5. Cell Migration and Invasion Assays 
The ability of MCF7 and MDA-MB-231 cells passing through Matrigel coated or 
uncoated filters was measured by the Boyden chamber invasion assay using Transwell 
inserts (8μm pores, Trevigen, MD). Cells were suspended in serum-free and phenol free 
DMEM and applied to the upper chamber. Serum and phenol free media with or without 
FCS as the chemotractant was added to the lower chamber and the plate incubated at 
37oC for 24hrs. Non-migrated cells in the upper well were removed and the membranes 
were fixed and stained using 0.01% crystal violet. The membranes were either 
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photographed or counted under a light microscope (×100) or the dye extracted and the 
absorbance reading obtained using a spectrophotometer. 
For the Matrigel invasion assay, transwell inserts coated with 0.5μg/ml Matrigel (BD 
Biosciences, MA) were used. Cells (105 per well) suspended in serum-free and phenol 
free DMEM were seeded onto the upper chambers of the precoated transwells. Serum and 
phenol free media with or without charcoal stripped FCS was added to the lower chamber 
and the plate incubated at 37oC for 24hrs. Subsequently, the membranes were fixed, 
stained, and photographed as above or absorbance readings acquired. 
4.3.6. Wound-healing Assay 
Cells were placed in inserts with a gap 500nm (+ 50nm) (Ibidi, Verona, WI) and 
incubated at 37oC. After serum starvation for 24hrs, the inserts were removed, the wells 
were washed with PBS and medium with or without 5% charcoal stripped FBS was 
added. Cell migration was determined under the inverted microscope and pictures were 
obtained at time = 0 and 16hrs. 
4.3.7. Anchorage-Independent Growth Assay 
Briefly, 1 × 103 cells of each cell line were suspended in 300ul of Dulbecco’s 
Modified Eagle’s medium containing 10% calf serum and 0.35% SeaPlaque low-melting 
temperature-agarose. These cells were plated over a 300ul layer of solidified Dulbecco’s 
Modified Eagle’s medium containing 10% calf serum and 0.6% agarose, and cells were 
allowed to settle to the interface between these layers at 37 °C. After 20 min, the plates 
were allowed to harden at room temperature for 30 min before returning to 37 °C. 100ul 
of vehicle control or IGF-1 was added to wells and the plate incubated at 37 °C. The 
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plates were fed every 2–3 days. After 12-14 days, colonies were photographed under low 
magnification (x10).  
 
4.3.8. RNA Isolation 
After treatments of 15minutes, 1hr or 24 hrs, total RNA from MCF-7 cells was 
extracted using an RNAeasy mini kit (Qiagen) according to the manufacturer's 
instructions. The integrity and purity of the total RNA were checked using a 
Spectrophotometer (GE Healthcare). 
4.3.9. Synthesis of Complementary DNA and Quantitative (real-time) PCR 
Complementary DNA (cDNA) was created using qScript™ cDNA synthesis kit 
(Quanta BioSciences). Q-PCR was performed using the CFX96™ Real-Time PCR 
Detection System (Bio-Rad) in a two-step procedure using SSo Fast (Biorad). 
Amplification of 18s was performed to standardize the amount of sample cDNA. Primer 
were 18s, Rab5a, Rab5b, MMP9 (Life Technologies). All reactions were performed in a 
96 well plate with the following cycling conditions: 40 cycles of 95°C for 15s, and 60°C 
for 30 s, 72°C 1 min. To report fold changes, ΔΔCt values were obtained and fold change 
is derived as 2−ΔΔCt with the value of each control sample was set at 1 and used to 
calculate the fold-change of target genes. 
4.3.10. Statistical Analysis 
All samples in this study were analyzed in duplicate and each experiment was repeated 
three times. Values represent the mean ± SEM of three independent experiments. To 
compare two groups, student’s t test was utilized. P < 0.05 was considered as statistically 
significant. 
115 
4.4. Results 
Rab5 and RIN1 regulated IGF-1 signaling induced morphological changes in MCF7 
cells consistent with Epithelial Mesenchymal Transition 
Previous studies have shown that there is an intrinsic relationship between IGF-1 
signaling and breast cancer34,41. Here, the morphological changes that occurred in MCF7 
breast cancer cells overexpressing Rab5 and RIN1, when treated with IGF-1, suggest this 
may be consistent with EMT. 
In Figure 14a, cells were treated with IGF-1, and subsequently stained with phalloidin 
to visualize the actin filaments. In IGF-1 treated cells, more actin accumulated to the edge 
of the cells (Figure 14a. arrows), particularly in Rab5 and RIN1 overexpressing cell lines. 
Further examination also illustrated that some cells underwent a shift in epithelial 
morphology as they were more elongated and fibroblast-like, and similar in 
morphological characteristics like the invasive breast cancer cell line, MDA-MB-23126. 
4.4.2 Inhibition of IGF-1R trafficking modulated cell migration and invasion of MCF7 
cells. 
As it was ascertained in Aims 1 and 2, both Rab5 and RIN1 expression is required for 
IGF-1 signaling which drive cell migration and invasion. It is known that IGF-1 signaling  
is dependent on IGF-1R activation9,24. IGF signaling is initiated by the binding of the 
IGF-1 ligand to the IGF-1R and the subsequent auto-phosphorylation of tyrosine residues 
of specific cytosolic kinase domains14,29,35 and the association specific adaptor molecules 
such as IRS, Shc25 and RIN123.  To determine if IGF-1 signaling was mediated through 
the IGF-1R in breast cancer cells, an IGFR  inhibitor, AG102432 was administered to the 
cells for 1hr prior to cell invasion and migration assays. 
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In Figures 14b and 14d, AG1024 abrogated migratory and invasive capacity of MCF7 
cells expressing either Rab5 or RIN1, thereby suggesting that the IGF-1R is involved 
IGF-1 signaling in breast cancer progression. Considering that Rab5 has been implicated 
in the endocytosis of RTKs, it was imperative that the actual mechanism of IGF-1R 
internalization was clarified. IGF-1R endocytosis has been said to be both clathrin and 
caveolin dependent30. The latter, however has a stronger affinity in IGF-1 signaling7,37 
and it was worth investigating if IGF-1 signaling in breast cancer was dependent on lipid 
raft formation. MCF7 cells were pre-treated for 1hr with the caveolin inhibitor i.e. 
Filipin, and the effect on migration and invasion observed using the Boyden chamber. 
Like the IGF-1R inhibitor, Filipin suppresses cell migration and invasion of MCF7 cells, 
particularly in RIN1 over-expressing cells. Cells overexpressing Rab5, while showing a 
decrease compared to the control, possessed a higher migratory and invasive potential 
like RIN1 expressing MCF7 cells, implying that there may be a possible link between 
RIN1 activity and caveolin invagination of the IGF-1R. 
4.4.3 Colony formation requires caveolin dependent IGF-1R trafficking 
During cancer progression there are two main phases of tumor formation, the onset of 
hyper-proliferative growth and primary colony formation during the pre-metastatic phase, 
and the secondary colony formation, post metastasis17. Based on previous results, it was 
illustrated that IGF-1 promotes aggressive tumor growth from single tumor cells in 
agarose suspension. Most importantly, it was dependent on Rab5 and RIN1 activity, 
suggesting that the IGF-1R may play an integral role in colony formation. In the presence 
of the AG1024 or Filipin inhibitors (Figure 14g), colony formation was significantly 
curbed, providing additional evidence that IGF-1R is involved in breast cancer 
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progression. Furthermore, this IGF-1R involvement requires trafficking to the early 
endosome via a caveolin dependent mechanism possibly through the invagination to the 
caveosome and docking on the early endosome. 
4.4.4 AG1024 and Filipin modulates cell migration and invasion in MDA-MB-231 cells 
Since cell migration and invasion was negated in MCF7 cells in the presence of 
inhibitors, it was interesting to see if in a highly invasive breast cancer cell line, the 
ability for cells to migrate and invade would also be affected. MDA-MB-231 cells were 
also transduced with GFP, Rab5 and RIN1 and pretreated with AG1024 or  Filipin for 
1hr. Migration and invasion was assayed using the Boyden chamber and after 18hrs, the 
absorbance of migrated and invaded cells was quantified. 
As expected, there was a reduction in cell migration and invasion in the presence of 
the kinase or caveolin inhibitor (Figures 15 a , c, d and e ). Unlike MCF7, Rab5WT-
expressing MDA-MB-231 cells migrated and invaded less than RIN1 cells. 
Cell migration and invasion was largely unaffected in RIN1:R94A cells compared to 
controls, implying that RIN1 is recruited upon IGF-1R stimulation prior to caveolin-
dependent internalization of the receptor. Figure 15b, illustrated that inhibition of the 
IGF-1R significantly affected migration in both Rab5WT and RIN1 breast cancer cell 
lines supplementing the data obtained that IGF-1R must be involved in IGF-1 signaling 
in breast cancer progression. 
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4.4.5 RIN1 mediates IGF-1 induced expression consistent with IGF-1R trafficking in 
breast cancer cells 
To determine if Rab5 expression is substantial upon IGF-1 stimulation in RIN1 
expressing cancer cells, real-time PCR was performed with primers for Rab5a and Rab5b 
in both MCF7 and MDA-MB-231. 
Figure 16a shows the role of Rab5a in cancer progression and the importance of the 
receptor in IGF-1 signaling during disease progression. In the presence of the kinase 
inhibitor, there was considerable down-regulation of Rab5a expression when   compared 
to IGF-1 control (where the fold change >2 is considered significant) in cancer cells 
overexpressing RIN1. Addition of Filipin also induced marked suppression of Rab5a in 
the presence of IGF-1. This clearly denotes that Rab5a function in IGF-1 signaling in 
breast cancer cells may be dependent upon caveolin mediate internalization of the IGF-
1R. In MDA-MB-231 cells, the outcome was similar to MCF7 with AG1024 repressing 
Rab5a gene activity (Figure 16d). To verify if other Rab5 isoforms may be involved in 
IGF-1R trafficking in breast cancer cells, Rab5b expression was observed. Surprisingly, 
Rab5b expression was comparable to Rab5a, where Rab5b was up-regulated significantly 
in the presence of IGF-1 and inhibited when AG1024 was introduced (Figures 16f).  A 
key finding (Figures 16c and e) demonstrated that Rab5 gene expression was affected in 
cells expressing RIN1:R94A mutant, indicating that the ability of RIN1 to bind to the 
activated receptor is necessary for Rab5 function in early endocytosis of the receptor. 
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4.4.6 Endocytosis of the IGF-1R increased metalloproteinase expression in breast 
cancer cells  
During cancer cell invasion, proteases are stimulated and secreted by growth factors 
including IGF-117,41. Given earlier data that illustrated acquisition of fibroblast like 
phenotype in MCF7 cells upon IGF-1 stimulation (Figure 14a), the next step was to 
ascertain if Rab5 and RIN1 trafficking of the IGF-1R facilitates protease expression. 
Using real time PCR with primers for MMP9 in both MCF7 and MDA-MB-231 cell 
lines, MMP9 gene expression was significantly enhanced in cell s overexpressing Rab5 
and RIN1. In MCF7 cell (Figure 17b), Rab5 expression elicited a 10-fold increase in 
MMP9 gene expression. RIN1 elicited lower but still significant levels of MMP9 mRNA, 
about 2.5 fold change in both MCF7 and MDA-MB-231 (Figure 17b and 17c 
respectively). Addition of  AG1024 and Filipin to MCF7 cells (Figure 17c) reduced 
MMP9 expression with the fold changes at 1 or less, supplementing the cell invasion data 
that the inhibitors repress the invasive capacity of MCF7 in the presence of IGF-1. While 
one of the traits of MDA-MB-231 is a highly invasive phenotype, it is shown that MDA-
MB-231 in response to IGF-1 can up-regulate MMP9 gene expression, via RIN1 activity 
(Figure 17d and e). Moreover, RIN1:R94A significantly suppressed MMP9 expression 
corroborating RIN1 and Rab5 roles in cell invasion. 
4.5. Discussion 
Proliferation, migration and invasion are regulated by a wide array of growth factors 
and cytokines in cancer metastasis8. Growth factor signaling are reliant on receptor 
phosphorylation and the utilization of specific inhibitors for RTKs  are  important in 
elucidating the role  growth factors and their receptors in membrane trafficking and 
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signaling 10 in cancer cell migration and invasion. In fact, RTK activation is pervasive 
during the endocytic process, from internalization to lysosomal and/or recycling 
processes.   
Here (Figures 14b and 14d), it was demonstrated that the IGF-1 inhibitor, AG1024, 
suppressed the invasive and migratory activity of MCF7 breast cancer cells indicating 
that IGF-1 signaling was dependent on the IGF-1R. Rab5a expression was significantly 
diminished when the IGF-1R was blocked (Figure 16a), implying that the receptor must 
be activated for Rab5 mediated early endocytosis to occur. Confirmation that 
internalization of IGF-1R can be clathrin independent30,37 was validated by the addition 
of Filipin, indicating that IGF-1R endocytosis is caveolin-dependent and entailed Rab5 
activation and early endocytic function (Figure 16b). Down-regulation of Rab5a through 
IGF-1R inhibition led to decreased cell invasion and migration, supporting previous 
reports from this study that growth factor driven cell migration and invasion was Rab5 
dependent in breast cancer cells. 
In MDA-MB-231 cells (Figures 15a and 15d), it appears that there was partial 
blocking of the IGF-1R in cells overexpressing RIN1, suggesting that IGF-1 signaling 
was also mediated by another mechanism independent of the IGF-1R. Within anchorage 
independent conditions, it was ascertained that IGF-1 interacts with the Integrin receptor 
(αvβ3) and facilitates IGF-1 signaling regardless of IGF-1R inhibition16. Integrins are 
heavily involved in the cell migration process  during cancer progression and Rab5 is 
known to regulate αvβ3 endocytosis 40. Hence, it can be assumed that during cell 
migration of breast cancer cells, IGF-1 can also stimulate the αvβ3 receptor, leading to 
the RIN1 interaction of Rab5 and sequestering of the active Rab5 complex to the cell 
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membrane and subsequent endocytosis of the αvβ3 receptor. On the other hand, RIN1 
binds to non-receptor ABL tyrosine kinases, where the latter arbitrates RTK 
phosphorylation and endocytosis, and directs actin remodeling in cell migration22,38. 
RIN1 directed endocytosis of the RTK and the ultimate fate of the receptor involves a 
delicate balance between RIN1:Rab5 and RIN1:ABL interaction3. Specifically, ABL 
confers a protective influence on  RTK activity, increase active Rab5 levels stabilized the 
receptor and shifted the mechanism to increased receptor internalization and recycling, 
and directed cell motility4. 
In Figure 15a, despite the presence of Filipin, MDA-MB-231 cells overexpressing 
RIN1 may utilize ABL signaling via IGF-1R phosphorylation, bypassing caveolae 
receptor internalization. Taken together, it can be concluded during IGF-1-directed cell 
migration and invasion in breast cancer, IGF-1 signaling is both dependent and 
independent on IGF-1R. 
IGF-1 has engendered morphological changes in breast cancer cells via TGF 
activation41 where atypical epithelial cells acquired an EMT configuration. This study 
revealed that in MCF7 cells overexpressing RIN1 and Rab5, IGF-1 stimulated breast 
cancer cells had modified morphological features as they were more elongated and 
fibroblast-like, typical of cells undergoing EMT17. During EMT, protease activity is 
integral, allowing cells to migrate and invade to distal tumor sites. Based on this, it was 
imperative to determine if MMP expression was correlated with IGF-1R trafficking in 
breast cancer cells. 
MMPs are intergral family of endopeptidases involved in the metastatic potential of 
cancer. Walsh et al highlighted that IGF-1 significantly increased MMP expression and 
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subsequently the proteolytic  and invasive response of MCF7 cells41 Few studies 
currently exist that illustrate the functional role of enodcytosis  in the regulation and 
trafficking of MMPs.  In breast cancer cell lines expressing the estrogen receptor, Rab27b 
has been implicated in the regulation of MMP-2 activation through heat shock protein 
(Hsp) 90a secretion and stimulate invasion of breast cancer cells19,31. Growth factor 
stimulated breast cancer cells overexpressing Rab5a affected Rab4 and Rabenosyn-5-
dependent endo/exocytic cycles in the ferrying of the matrix protease, MMP-1 and β3 
integrin15. This trafficking cycle produced a chemotactic-dependent invasive and 
proteolytic mesenchymal response in breast carcinoma cells in vitro and in vivo15. 
Here, it is shown that an inherent relationship may exist between endocytosis and 
MMP9 activity in the presence of IGF-1. In both ER positive and ER negative cell lines, 
MMP9 expression increased in response to IGF-1 stimulation (Figures 17a-e). Inhibition 
of the IGF-1R suppressed MMP9 levels showing persuasive the role of IGF-1 signaling 
in breast cancer cell invasion (Figures 17c and e). In the archetypal non-invasive MCF7 
cells line, Rab5 over-expression garnered the most positive change in MMP9 gene 
expression (Figure 17b). This hints, not only of the potency of IGF-1 in accelerating the 
alteration to an aggressive breast cancer phenotype and behavior, but also the importance 
of Rab5 in mediating protease secretion and action during IGF-1R trafficking in breast 
cancer cell invasion. 
As described above, IGF-1R internalization is caveolin dependent as Filipin hindered 
MMP9 gene expression in response (Figure 17c). Conversely, given the highly invasive 
nature of MDA-MB-231 cells, it was expected that MMP9 expression would be more 
dominant compared to MCF72. Yet, MMP9 gene expression, while significant, was 
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almost the same (about 2.5 fold) compared to protease expression in MCF7 cells. Perhaps 
this can be ascribed to the fact that as MDA-MB-231 is already highly invasive, the 
change in MMP9 expression in response to growth factor would not be as drastic 
compared to the MCF7 cells undergoing IGF-1-mediated transformation to an aggressive 
status. As expected, the RIN1:R94A cell line affected MMP9 expression. Therefore the 
inability for RIN1 to bind to the IGF-1R down-regulated MMP9 expression (Figures 
17d). 
In summation, this study illustrates a novel model in IGF-1 signaling in breast cancer 
progression. IGF-1 signaling relies heavily on the IGF-1R activation and caveolae-
dependent trafficking through Rab5 and RIN1 activity. Additionally, this study show for 
the first time that there may be a link between caveolin dependent endocytosis and RIN1 
activation in IGF-1 signaling. RIN1 overexpression increases endogenous caveolin-1 in 
early endosomes, and upon internalization, translocation and tethering of active 
caveosomes to the early endosomes is  Rab5 dependent33.  The interplay between IGF-1R 
trafficking and MMP9 activation through RIN1 and Rab5 GTPases function elucidates 
one of the mechanisms of invading breast cancer cell. With the establishment of Rab5 
and it GEF, RIN1 as crucial regulators in IGF-1 signaling in cancer cell migration and 
invasion, characterization of the RIN1- caveolin interaction as well as downstream 
signaling pathway need to be further studied. 
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(f)                                                Invasion 
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Figure 14a Rab5 and RIN1 influenced morphological changes in MCF7 cells when 
treated with IGF-1. Figure 14a illustrated the mobilization of actin fibers in MCF7 cells 
to the cell surface in response to IGF-1 with a strong response in Rab5 and RIN1 cell 
lines. Cells were seeded on coverslips, incubated for 18hrs in the absence or presence of 
IGF-1. After fixing and staining with actin phalloidin, the prepared slides were observed 
under a confocal microscope. Cytoskeleton was stained with phalloidin (red) and the 
nucleus with DAPI (blue) with more actin (red) was seen accumulating to the cell surface 
in IGF-1 treated cells. In MCF7 cell lines, IGF-1 signaling requires IGF-1R activation 
and dependent on caveolin mediated internalization. Figures 14b, c ,e and f, migration 
and invasion of the tumor cells were affected by both the kinase and caveolin inhibitors. 
Cells were plated in a Boyden chamber without or without basement extract membrane. 
Both kinase and caveolin inhibitors were added to cells for 1hr. Treatment groups were 
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IGF-1 or vehicle control and cells were incubated ta 37oC for 16hrs. Crystal violet 
staining was performed and the dye extracted and the OD measuring using a plate reader 
at 595nm. Cell migration and invasion absorbance readings were expressed as average ± 
SEM for three independent experiments. Using an IBIDI gap closure system, Figure 14d 
is a representative picture depicting the effect of AG1024 on cell migration MCF7, where 
blocking of IGF-1R signaling down-regulated IGF-1R trafficking in Rab5 and RIN1 
overexpressing MCF7 cells. In Figure 14g, cells were pretreated for 1hr with the 
inhibitors, followed by sparse seeding in agarose and cultured for 14 days with or with or 
without IGF-1. At the end, pictures of colony formation from single cells were taken and 
the average number of colonies were calculated for 3 random areas of each well. As 
shown, both Rab5 and RIN1 cells had more colonies in response to IGF-1. Inhibition of 
the IGF-1R and caveolin suppressed colony formation particularly in response to IGF-1. 
(*) denotes (P<0.05), (**) is (P<0.01), (***) is (P<0.001) 
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(d)                                                 Invasion 
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(e)                                              Invasion 
 
 
Filipin suppresses cell migration and invasion of MDA-MB-231 cells upon IGF-1 
stimulation. (Figures 15a, c, d, e) Cells were plated in a Boyden chamber without or 
without basement extract membrane. Both kinase and caveolin inhibitors were added to 
cells for 1hr. Treatment groups were IGF-1 or vehicle control and cells were incubated ta 
37oC for 16h. Crystal violet staining was performed and the dye extracted and the OD 
measuring using a plate reader at 595nm. Cell migration and invasion absorbance reading 
were expressed as average ± SEM for three independent experiments. (*) denotes 
(P<0.05), (**) is (P<0.01), (***) is (P<0.001). In Figure 15b, an IBIDI culture insert 
(IBIDI GmbH) was placed into wells of a 24 well plate and slightly pressed on the top to 
ensure tight adhesion. An equal number of cells were placed in each of the insert and the 
cells incubated for 16hrs. Gap closure was observed at a magnification of 10X and 
images recorded. Crystal violet staining was done for better imaging of the migration of 
the cells 
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Figure 16 
(a)  
 
 
(b) 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
vehicle ctrl IGF1R
el
at
iv
e 
m
R
N
A
 e
xp
re
ss
io
n 
(A
ve
ra
ge
 
Fo
ld
 c
ha
ng
e 
co
m
pa
re
d 
to
 1
8s
 c
on
tro
l)
Rab5a
vehicle ctrl
IGF1
MCF7
-1
1
3
5
7
9
11
13
NT AG1024 FilipinR
el
at
iv
e 
m
R
N
A
 e
xp
re
ss
io
n 
(A
ve
ra
ge
 fo
ld
 
ch
an
ge
 c
om
pa
re
d 
to
 1
8s
 c
on
tro
l)
Rab5a
vehicle ctrl
IGF1
MCF7:RIN1 cell line
136 
(c)   
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Figure 16. Real time PCR showed Rab5 expression and activation is dependent on 
IGF-1R phosphorylation and internalization via caveolae-mediated mechanism. 
Figure 16a shows Rab5a expression in wildtype MCF7 cells after IGF-1 stimulation. 
MCF7and MDA-MB-231 cells overexpressing RIN1 were pre-treated with AG1024 or 
FIlipin for 1hr and treated with IGF-1 or vehicle control. In Figure 16b, Rab5a levels was 
11 fold compared with a sharp decrease in Rab5a expresson in the presence of the 
inhibitors. Figures 16 c and d complements the MCF7 data, showing Rab5a expression 
was also elevated upon IGF-1 stimulation and reduced in the presence of AG1024 and the 
RIN:R94A mutant. Rab5a, had a 4-fold increase in gene expresson with similarly 
inhibition of Rab5b gene levels in the presence of AG1024 in R94A cell lines. 
 
 
Figure 17 
(a)  
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(b) 
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(d)  
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(e) 
 
Figure 17. Real time PCR showed MMP9 expression and activation is dependent on 
IGF-1R phosphorylation and internalization via caveolae-mediated mechanism. 
MCF7 and MDA-MB-231 cells overexpressing Rab5a and RIN1 were pre-treated with 
AG1024 or Filipin for 1hr and treated with IGF-1 or vehicle control. Figure 17a. depicts 
MMP9 expression at an early and late time. In (b), MMP9 expression was notably 
elevated 11 fold compared to the vehicle control in 7 cells while in (d), disruption of the 
caveolae pathway also inhibited MMP9 expression while in RIN1:R94A mutant cells, 
MMP9 expression was also decreased. Figures (c) and (d) shows that the blocking of the 
IGF-1R affected MMP9 gene levels in both MCF7 and MDA-MB-231 cells 
overexpressing RIN1. 
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Chapter 5 
5.1. General Discussion 
Endocytosis is a process where cells ingest macromolecules and particles via 
membrane bound substances. These events allow cells to digest and also recycle 
molecules to the exterior space. This process is called exocytosis and it functions 
opposite to endocytosis. These processes regulate several cellular mechanism from 
protein secretion, RTK endocytosis, recycling and degradation.  Disruption of 
endocytosis within RTK trafficking has been linked to modifications in cellular processes 
such as adhesion, migration, proliferation, polarity, asymmetrical division and overall cell 
survival and  represent the importance of Rab GTPases in cancer initiation and 
progression131.  
Rab GTPases are considered to be master regulators of a multitude of trafficking 
pathways. Factors such as HGF, EGF, TGFβ and IGF are known to activate the 
endosomal and exocytic pathways, thereby altering cell communication with the 
environment. The mechanisms can be comparable at key junctions where actin filaments 
and integrins are mobilized thereby promoting a migratory response in tumor cells.  
These RTKs can be internalized through two principal pathways: clathrin-coated pits or 
caveolae. In IGF-1 signaling, recent evidence highlighted an increase in cell proliferation 
and inhibition of apoptosis upon IGF-1R stimulation and ensuing internalization via co-
localization with clathrin and caveolin-1123. IGF-1R is also localized in the nucleus in 
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prostate, renal and breast tumor cells after translocation from the cell surface via clathrin 
mediated endocytosis.2 
Recently, more attention has been directed to the mechanisms involving cancer 
progression and Rab GTPases function131. Cell migration and invasion constitute key 
hallmarks of cancer and specifically cancer metastasis69. The transitions to a malignant 
and aggressive phenotype by normal cells are site specific 54. It also involves a variety of 
Rab proteins that have been implicated in the transition to metastasis where cells become 
invasive and penetrate the basal cell membrane and the ECM32,37. These cells secrete an 
array of proteases such as MMPs; induce the compromised basement membrane to 
further release more proteases such as collagenase and growth factors, thereby allowing 
cancer cells to breach the basal membrane and migrate to distal sites. 
As the role of growth factor-driven endocytosis in cancer cells is slowly being 
characterized, part of the struggle that currently exists involves the correct identification 
of the crucial endocytic molecules in growth factor signaling that may be potential 
therapeutic targets in cancer treatment. These may include but are not limited to Rab5, 
and its effectors49,172. This report outlines an inherent relationship between Rab GTPases 
and IGF-1 in cancer cell migration and invasion. Whilst most Rabs are currently not 
considered to be oncogenic, this study otherwise provides evidence that some Rabs may 
be indeed so.  
Here, it is reported for the first time that Rab5 and well as, RIN1, a specific Rab5 
GEF, are central players in migration and invasion of MCF7 cells especially in the 
intracellular trafficking and signaling of the activated IGFR.  The typically non-invasive 
MCF7 breast cancer cells were transfected with Rab5WT, Rab5 mutants (the GDP bound 
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form Rab5:S34N or GTP bound form Rab5:Q79L) or RIN1WT and the invasive and 
migratory potential were investigated.  Interestingly, Rab5WT, Rab5:Q79L and RIN1 
mediated significant migration and invasion of the tumor cells, with RIN1 and 
Rab5:Q79L also showing an induction (though not as significant) in the absence of IGF-
1. The inactive form of Rab5, Rab5:S34N inhibited proliferation, migration and invasion 
of the cancer cells confirming Rab5 must be active and is necessary in IGFR endocytosis 
in IGF-1-dependent cancer cells. Further characterization of RIN1 importance in RTK 
trafficking was determined when transient silencing of RIN1 expression negated invasion 
of tumor cells. Other GEFs of Rab5 were also shown to influence the migratory and 
invasive potential of breast cancer cells with RIN3 demonstrating a more profound effect 
compared to RIN2.  
Given that non-invasive tumor cells were directed to an aggressive status, it was 
logical to verify if in an invasive breast cancer cell line, MDA-MB-231, Rab5 and its 
GEFs are required in IGF-1 signaling. Using a stably transfected MDA-MB-231 cell line 
expressing Rab5:S34N, it was observed that the invasive and migratory properties 
increased irrespective of growth factor stimulations while the invasive potential of breast 
cancer cell lines expressing the wild type and active (GTP-bound) form of Rab5 were 
noticeably greater.  Of interest, the expression of RIN1 increased invasion and migration 
of MDA-MB-231 cells even in the absence of growth factors. The results obtained 
warranted additional inquiry into the mechanism of RIN1 in enabling IGFR intracellular 
trafficking and signaling, i.e. through interaction with the receptor itself or only as a 
switch in Rab5 activation.  The RIN1 mutant, RIN1:R94, possessed an aberration in the 
SH2 binding domain. This study clearly illustrated that RIN1 interacts with the cystolic 
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tail of the IGFR as cancer cells expressing RIN1:R94A partially mitigated invasion and 
migration.  
Thus far, IGF-1-induced migration and invasion of breast cancer cells necessitate 
active Rab5 sequestration via RIN1 activity. Consequently it was crucial to validate 
previous findings and ascertain if IGFR trafficking was caveolin dependent. IGF-1 
treatment of MCF7 cells induced morphological changes consistent with EMT 
particularly in Rab5 and RIN overexpressing cells, i.e. more elongated and fibroblast- 
like. When kinase inhibitor for IGFR, AG1024 and caveolin inhibitor, Filipin, were 
administered to both MCF7 and MDA-MB-231 expressing, GFP, Rab5 or RIN1 
constructs, the inhibitors impaired the migratory and invasive response of the breast 
cancer cell lines, suggesting that IGFR phosphorylation and internalization of the 
activated receptor was mediated by caveolin and caveosome formation upon IGF-1 
stimulation.  How does Rab5 and RIN1 fit into this schematic? Analysis of mRNA 
expression indicated that blocking of the IGFR or disruption of caveolin signaling in 
breast cancer cells expressing GFP or RIN1, suppressed Rab5 gene expression as well 
MMP9 secretion. The latter substantiates cell invasion data where the inhibitors averted 
the phosphophorylation of the IGFR and its internalization despite RIN1 and Rab5 
overexpression. Overexpression of Rab5 induced a significant increase in MMP9 
expression and down-regulation in the presence of the inhibitors.  In summation, this 
study illustrates a novel model in IGF-1 signaling in breast cancer progression. IGF-1 
signaling is contingent on the IGF-1R phosphorylation and caveolae internalization via 
Rab5 and RIN1 function. Furthermore, it is reported that there may be a link between 
caveolin-dependent endocytosis and RIN1 activation in IGF-1 signaling. RIN1 
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overexpression has been shown to increase endogenous caveolin-1 in early endosomes, 
and upon internalization, translocation and tethering of active caveosomes to the early 
endosomes is  Rab5 dependent154.  Therefore, the relationship between IGF-1R 
trafficking and MMP9 production is dependent on the activity of early endocytic 
trafficking machinery; thus RIN1 and Rab5 GTPases function within invading breast 
cancer cells. 
 
 
5.2 Future Plans 
Endocytosis is an indispensable molecular mechanism in growth factor induced 
signaling, and it is worth considering that early factors such as small GTPases and its 
GEFs exert a great influence on intracellular trafficking. Most importantly it is a 
coordinator in the crosstalk amongst signaling pathways in the propagating and 
promoting cancer cell survival. Further description of these small GTPases (e.g. Rab) 
function in cancer cell proliferation, migration and invasion, would be beneficial as these 
Rabs can be prospective biomarker in determining cancer stage and outcome prognosis. 
This idea opens the doors for the development of new therapeutic methods to target these 
necessary factors such as siRNA or peptide manipulations that can selectively affect Rab 
effectors.  
While this study also demonstrates that Rab5 is a central player in the migration and 
invasion of cancer cells especially in response to IGF-1 stimulation, other questions 
abound including the role or activity of downstream effectors (PI3K and MAPK) in 
facilitating cell migration and invasion and as well as the mobilization of cytoskeletal 
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proteins such as focal adhesion kinase (FAK) and integrin receptor in IGF-1 mediate 
cancer progression. Even though it has been suggested that Rab5 modulates focal 
adhesion kinase activity in  normal and cancer cells 127, yet little information is available 
as to how growth factors (i.e. IGF-1) regulate the molecular mechanisms of intracellular 
processes leading to survival in normal and cancer cells. 
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